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The oxidative protein folding (OPF) pathway is conserved across prokaryotic and 
eukaryotic organisms. In yeast, the OPF is catalysed by the essential proteins 
protein disulphide isomerase (PDI) and endoplasmic reticulum oxidoreductin 
(Ero1p) within the endoplasmic reticulum (ER). It is unclear why PDI1 is an essential 
JHQHDVXSUHJXODWLRQRIVRPH\3',KRPRORJXHVFDQ UHVWRUHYLDELOLW\ WRD¨pdi1 
strain. The essentiality of PDI was therefore investigated to identify a potential 
VXSSUHVVRU RI ¨pdi1 lethality (supX), with the hypothesis that supX would be 
upregulation of yPDI homologues. As the purpose of the non-essential yPDI 
homologues is unknown this would help characterise the yeast OPF pathway as 
well as providing a potential mechanism to increase OPF in vivo. A genetic screen 
was carried out to search for potential extragenic suppressors of the lethality seen 
LQD¨pdi1 mutant using a plasmid shuffling strategy.   A number of viable mutants 
were obtained but these arose either via genomic recombination with the plasmid-
borne PDI1 or through direct resistance to 5-FOA used in the screen. Two other 
PDI-less mutants obtained showed a loss of viability upon storage. Glutathione 
peroxidase 7 (GPx7) and glutathione peroxidase 8 (GPx8) are ER localised 
mammalian proteins that couple the detoxification of hydrogen peroxide (H2O2) to 
reoxidation of PDI, simultaneously alleviating H2O2 stress in the ER and increasing 
the rate of OPF. There are no known ER-localised peroxiredoxin proteins in S. 
cerevisiae and so GPx7 and GPx8 were expressed in yeast to remove accumulated 
H2O2 as this may be a limiting factor in OPF. Neither GPx7 nor GPx8 had any effect 
on levels of intracellular H2O2 in vivo or cellular sensitivity to H2O2. Furthermore 
there was no effect on the rate of OPF in vivo and in vitro. It is possible that there is 






Chapter 1 ± Introduction 
1.1 The oxidative protein folding pathway 
The oxidative protein folding (OPF) pathway is a highly conserved system in both 
eukaryotes and prokaryotes as disulphide bonds are essential for the proper activity 
of many proteins(1). In eukaryotic cells the OPF in proteins synthesised in the 
secreted protein pathway are catalysed in the endoplasmic reticulum (ER) by protein 
disulphide isomerase (PDI) and endoplasmic reticulum oxidoreductin 1 (Ero1).  
1.1.1 Components of the yeast endoplasmic reticulum oxidative protein 
folding pathway 
1.1.1.1 Protein disulphide isomerase 
PDI is an endoplasmic reticulum (ER) localised protein which primarily has roles in 
OPF and isomerisation(2). In humans there are 21 known members of the PDI 
family(3), whereas yeast expresses only a single known essential PDI(4) protein 
encoded for by the PDI1 gene, with four non-essential homologues(4). PDI is within 
the top 4% of most abundant proteins at ~66000 molecules per cell(5) and it accounts 
for 2% of protein in the ER(6).  
3',KDVGRPDLQVDD¶ E¶EDQGFZLWKDQ[OLQNHUGRPDLQFRQQHFWLQJWKHD¶DQG
E¶GRPDLQV IRUPLQJD µWZLVWHG8¶ IRUPDWLRQ(7) (Fig 1.1.). The 522 amino acid long 
yeast PDI (yPDI) molecule is approximately 80Å wide, 60Å tall(7) and has a 
molecular weight of ~58.2 kDa. The a, a¶E¶DQGEGRPDLQHDFKFRQWDLQDYDULDQWRQ
Fig 1.1. Structure of yeast PDI 
Ribbon diagram of the structure of yeast PDI, the DSXUSOHEF\DQE¶\HOORZD¶UHG






a thiorexodin fold(7), a common fold found in enzymes for catalysis of reduced thiol 
domains to disulphide bonds(8).   
The active sites of PDI are located in WKHDDQGD¶GRPDLQV of yPDI (Fig 1.1.) and 
consist of a CGHC domain(9) in the N-WHUPLQDOUHJLRQRIWKHVHFRQGĮKHOL[WKLVLVD
conserved characteristic across the thioredoxin family(10). From C61 of the first 
catalytic domain to C406 of the second measures 28Å, this opening and the 
hydrophobic cleft results in PDI being able to contain a peptide of approximately 100 
residues(7). 
There are several key resides involved in substrate binding other than the pair of 
cysteines directly involved in catalysis, one of which is a conserved tyrosine residue 
located immediately prior to the active sites, this hydrophobic residue is likely to be 
important for substrate binding as point mutations of these amino acids to non-
hydrophobic residues cuts the oxidative activity of PDI by ~50%(7). Another 
important residue is the glycine domain located between the two cysteines in the 
CGHC catalytic site, the absence of a side chain on this residue may increase 
flexibility of the active site(7). 
The orientation of the domains of PDI established from the crystal structure 
suggests WKDWWKHDGRPDLQLVLQFRQWDFWZLWKERWKWKHEDQGE¶GRPDLQVZKLOHWKHD¶
GRPDLQLVRQO\DEOHWRFRQWDFWWKHE¶GRPDLQ(7)7KHD¶DQGE¶GRPDLQVDUHFRQQHFWHG
via the x-linker (Fig 1.1.), a 17 amino acid peptide. The x linker gives a large degree 
of fle[LELOLW\ WR WKH D¶ UHODWLYH WR WKH E¶ GRPDLQ DOORZLQJ LW WR WLOW DQG WZLVW(11), this 
flexibility provides PDI with specificity for a greater range of substrates. All of the 
domain linking regions display flexibility, but none to the same degree as the x linker 
domain. The interdomain junction between the a and b domains are restricted to a 
WZLVWZKLOHEHWZHHQWKHEDQGE¶GRPDLQVWKHUHLVQRDELOLW\IRUWZLVWLQJ(11). The lesser 
IOH[LELOLW\RIWKHEDQGE¶GRPDLQVIRUPDVWDEOHEDVHIRUWKHµ8¶VKDSHRIWKHprotein 
ZKLOHWKHDDQGD¶GRPDLQVKDYHLQFUHDVHGIOH[LELOLW\IRUDOORZLQJDZLGHUDQJHRI
substrates into the cleft.  
7KHDDQGD¶GRPDLQVRI\3',EDUHVWULNLQJUHVHPEODQFHWRHDFKRWKHUEXWSRVVHVV
a few distinct differences that give them different characteristics(7). One of these 
distinct differences are the native redox states of the active sites, predominantly the 
DFWLYHVLWHD¶GRPDLQH[LVWVLQDSDUWLDOO\R[LGLVHGVWDWHZKHUHDVWKHDGRPDLQH[LVWV
predominantly in the fully oxidised state(7)(12)(13). 
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7KH LQGLYLGXDO D¶ DQG D GRPDLQV SRVVHVV KLJK R[LGDWLYH DFWLYLW\ KDYLQJ
approximately 50% of the activity as WT yPDI, but only 5% of the isomerase 
activity(13)(14)$GGLWLRQDOO\DVROH\3',D¶GRPDLQH[SUHVVHGLQ\HDVWLQDSSUR[LPDWHO\
double concentrations is able to rescue cells viability, this indicates that the oxidative 
activity of yPDI is essential for cell viability and that the isomeration activity is less 
essential(14). Expressing just 60% of the WT levels of PDI maintain growth rates 
similar to those of WT(14), this suggests that yPDI is expressed in greater quantities 
than is required for the cell and that high isomerase activity is not required for 
viability.  
The C terminal tail of PDI is an acidic C terminal extension from residues 486 to 522 
which forms an alpha helix(7). This domain helps maintain the native state of PDI 
enabling chaperone activity(15). This stability is likely induced by a relatively high 
composition of negatively charged residues(7)(16). 
There are external hydrophilic regions that gives PDI its solubility but there are also 
a number of external hydrophobic regions, two of which are present around the 
active sites of domains a(17) DQGD¶DQG WKHUH LVDQH[SRVHGK\GURSKRELF UHJLRQ
SUHVHQW RQ WKH E DQG E¶ GRPDLQV ZKLFK UHVXOWV in a continuous hydrophobic 
surface(7)7KHFRQWLQXDWLRQRIWKHK\GURSKRELFUHJLRQVIURPWKHE¶GRPDLQLQWRWKH
b domain increases the binding area for potential substrates(7). This hydrophobic 
surface likely has a role in generating the high affinity, wide specificity of PDI(18) that 
enables binding and catalysis of a wide range of protein substrates and also 
IDFLOLWDWHV 3',¶V FKDSHURQH DFWLYLW\ In vitro studies have demonstrated that it is 
possible that absence of the b domain results in lowered efficiency of folding of 
VFUDPEOHGSURWHLQEXWQRWRI UHGXFHGSURWHLQZKLOH ORVVRIE¶GRPDLQ UHVXOWHG LQ
lowered efficiency of OPF of both scrambled and reduced proteins(7). 
1.1.1.2 Endoplasmic reticulum oxidoreductin 1 
ERO1 is an essential gene(19) in yeast for disulphide formation and encodes 
Endoplasmic Reticulum Oxidoreductin 1(Ero1p), an ER protein that facilitates 
reoxidation of PDI. Ero1p is a flavoprotein as it has a non-convelantly bound flavine 




Ero1p has two pairs of cysteines that are involved in reoxidation of PDI: C100/C105 
and C352/C355, named the shuttle cysteines and active-site cysteines 
respectively(21). These residues are essential for efficient OPF in the ER(21). The 
shuttle cysteines are located in approximately the first 100 residues forming a 
flexible loop which can assume at least two conformations. A conformation that 
brings the shuttle cysteines in close proximity to the active site cysteines(22) and a 
distant conformation that may enable interaction of the shuttle cysteines with PDI(23) 
(Fig 1.2.). 
 
As well as these catalytically active disulphide bonds there are also six cysteines 
that partake in the formation of three regulatory disulphide bonds: C90/C349, 
C150/C295 and C143:C166(24) (Fig 1.2.). While these cysteine pairs are reduced 
Ero1p is active, however, should either of these regulatory cysteine pairs become 
oxidised Ero1p inactivates(24). This therefore forms a negative feedback loop where, 
should the ER conditions become more oxidising, the regulatory cysteine pairs will 
form disulphide bonds and hence inactive Ero1p. The inactivation of Ero1p will 
prevent the ER environment from becoming even more oxidising. Additionally there 
is evidence that regulation upon Ero1p can mediate the flow of oxidising molecules 
to the ER and therefore provides homeostatic control over the redox environment of 
the ER(24). 
Fig 1.2. Structure of Ero1p 
A ribbon diagram of the structure of Ero1p that shows the shuffle cysteine pair (C100-
C105) on the flexible peptide, the active site cysteine pair (C352-C355) which is in close 
proximity to FAD and the pairs of regulatory cysteines (C90/C349, C150/C295, 
C143/C166). Figure from Gross, E., et al(22) 
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The structural mechanism by which Ero1p regulation is achieved through the redox 
states of the regulatory cysteines C90/C349 and C150/C295 is likely due to the 
dependence on the motility of the flexible polypeptide for protein function(24). Both of 
these pairs of these cysteines capable of forming disulphide link the flexible 
polypeptide to the helically structured domain of the protein(24). Therefore oxidation 
of either regulatory cysteine pairs would result in decreased motility of the flexible 
polypeptide and by extension, the shuffle cysteines(24). This would prevent transfer 
of the electrons from the shuffle cysteines to the active-site cysteines as a 
conformational shift is a key step in the electron transfer in Ero1p(24), or, if locked in 
an alternate conformation, could prevent interactions of shuffle cysteines with PDI. 
There is cooperation between these two disulphide bonds relating to Ero1p 
UHJXODWLRQRQLWVRZQWKH&&ERQGLVQ¶WVWDEOHEXWLVJLYHQVWDELOLW\WKURXJK
the concurrent formation of the C150/C295 disulphide bond(24). 
Ero1p, in the absence of substrate, is able to self-oxidise its regulatory disulphides 
this allows Ero1p to inactive itself preventing uncontrolled oxidative activity in the 
lack of substrate(24).  
1.1.2 The mechanism of oxidative protein folding in yeast 
The OPF of target proteins initiates with the binding of unfolded protein to PDI. The 
E¶GRPDLQLVHVVHQWLDODQGDFWVDVWKHSULQFLSOHELQGLQJVLWHIRUOLJDQGV$FWLQJVROHO\
WKH E¶GRPDLQ LVDEOH WR ELQG VPDOO SHSWLGHV EXW IRU ODUJHU RUPLVIROGHGSURWHLQV
additional domains are necessary to facilitate binding(18). The b domain is 
UHVSRQVLEOHIRUOLJDQGDOLJQPHQW5HPRYDORIWKHD¶DDQGFWHUPLQDOGRPDLQVIURP
PDI do not result in a decrease affinity of substrate binding in vitro(25). 
)ROORZLQJVXEVWUDWHELQGLQJWKHUHGR[DFWLYHDDQGD¶GRPDLQVRI3DI catalyse OPF 
within substrate proteins (Fig 1.3.). The highly conserved CGHC site of either the a 
RUD¶GRPDLQVRI\3', LQ LWVR[LGLVHGIRUPR[LGLVHVDSDLURIF\VWHLQHV LQD WDUJHW
peptide forming a disulphide bond(26) ,Q K3', KRZHYHU WKH D¶ GRPDLQ oxidises 
WDUJHW SURWHLQV ZKLOH WKH D GRPDLQ UHR[LGLVHV WKH D¶ GRPDLQ WKURXJK GLVXOSKLGH
transfer(27).  
For PDI to catalyse formation and isomerisation of disulphide bonds in a wide range 
of proteins it must be able to distinguish stable, correctly folded proteins from 
unfolded proteins or proteins with non-native disulphide bonds. In human PDI this 
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is achieved through altered affinities for the different types of substrates, unfolded 
proteins bound with the highest affinity, partly folded proteins had a KD 
approximately 3x higher than the unfolded proteins and native proteins had a KD 
approximately 9 times higher than the unfolded proteins(25). As PDI is able to bind 
not only unfolded protein but also native protein, albeit weakly, suggests that 
substrate binding to PDI is mediated by exposure of unfolded regions to the catalytic 
site(25). As native proteins undergo regular, short-lived, conformation alternations 
resulting in exposure of domains associated with being unfolded hence allowing 
binding to PDI(25). Unfolded substrates therefore bind to PDI with higher affinity than 
partially folded or native proteins and undergo OPF. The OPF of unfolded protein 
results in a decrease in affinity of the protein which allows Ero1p, which has a KD of 
approximately 1.7µM with reduced PDI(27) in human cells. This is significantly lower 
than the KD of partially folded protein: ~4.9(25), to bind. It is likely that in yeast the 
change in affinity for substrate following OPF mediates substitution of protein 
substrate for Ero1p in a similar manor. 
 
Fig 1.3. The pathway of OPF in yeast 
The OPF of unfolded target proteins is catalysed by oxidised PDI through disulphide 
exchange, which therefore becomes reduced as a result (1). PDI can also isomerase non-
native disulphide bonded proteins to the correct native folding (2). Reduced PDI is reoxidised 
by oxidised Ero1 which in turn becomes reduced (3). Ero1 is reoxidsed by passing the 






Oxidative of protein folding of substrate by PDI leaves the enzyme in the reduced 
state (Fig 1.3.). Therefore for continued OPF reactions to occur PDI must be 
reoxidised, this is performed by Ero1p. Estimates for numbers of molecules of Ero1p 
VXJJHVWWKDWWKH\¶UHDWth that of PDI(27). Although typically Ero1p is responsible 
for reoxidation of the active site of PDI, evidence shows that some alternate electron 
acceptors, such as reduced glutathione (GSH), are capable of reoxidiVQJ WKH D¶
domain of hPDI(27).  
+XPDQ(URĮLQWHUDFWVZLWK3',WKURXJKFRQWDFWRIDȕ-KDLUSLQRI(URĮDQGWKHE¶
domain of hPDI(28) KRZHYHU \HDVW GRHV QRW KDYH WKLV ȕ KDLUSLQ DQG KHQFH WKH
mechanism of interaction of Ero1p with PDI likely differs between human and yeast 
systems(28).  
Reoxidation of PDI initiates through reduction of the shuttle cysteines in the flexible 
polypeptide loop of Ero1p by one of the reduced thiols of PDI(23), in yPDI the a 
GRPDLQPRUHUHDGLO\GRQDWHVHOHFWURQVWKDQWKHD¶GRPDLQ(12). The electrons of the 
thiol of PDI are passed to C105 and a temporary disulphide bond is formed between 
the now oxidised thiol of PDI and C100 of Ero1p resulting in the partially oxidised 
state of PDI(23) (Fig 1.4.).  The electrons from the second thiol of PDI is then passed 
to C100 of Ero1p resolving the bond between Ero1p and PDI and leaving oxidised 
PDI and reduced Ero1p(23) (Fig 1.4.).  
There are shifts in conformation of the flexible polypeptide domain resulting in a 
decreased distance between the shuffle cysteines and the active-site cysteines 
enabling disulphide transfer to occur(23) (Fig 1.4.). The reduced shuffle cysteines 
then attack the disulphide bond of the active-site cysteines, the electrons from C105 
are passed to C355 and a temporary disulphide bond forms between C100 and 
C352(23) (Fig 1.4.).  Electrons from C105 resolves this disulphide bond leaving the 
active-site cysteines reduced and the shuffle cysteines oxidised, the flexible 
polypeptide then returns to the original conformation and the Ero1p molecule is 
ready to oxidise another molecule of PDI(23) (Fig 1.4.). 
The active-site cysteines, C352/C355 are surrounded by 4 alpha helices and is in 
close proximity to the isoalloxazine of FAD(22). The active-site cysteines then donate 
2 protons to the FAD cofactor which becomes reduced(22). The FAD cofactor then 
donates the 2 protons to the final electron acceptor: molecular oxygen(22), resulting 
in the formation of one hydrogen peroxide (H2O2) molecule for each disulphide bond 
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oxidised. In anoxic conditions Ero1p is able to utilise an alternative to molecular 
oxygen for the final electron acceptor, such as free oxidised FAD(29). 
 
The flexible peptide of Ero1p does not just facilitate disulphide exchange between 
the shuffle and active-site cysteines. It also likely obstructs the active-site cysteines 
from direct binding of substrates requiring oxidation which would result in non-
specific formation of disulphide bonds(23).   
The components of the OPF pathway are under careful regulation governed by the 
oxidising conditions of the ER. Excessive oxidising conditions in the ER leads to 
inactivation of Ero1p which would also result in accumulation of reduced PDI, which 
may have enhanced isomerase activity(30), enabling it to refold non-native disulphide 
bonds that would form in an oxidising environment, as well PDIs chaperone activity 
being dependent upon the protein being in the reduced state(31). Regulation of Ero1p 
is primarily governed through PDI and assisted by reduced substrate as PDI is able 
to directly reduce the regulatory bonds of Ero1p(32). The oxidation of PDI can be 
catalysed by inactive Ero1p which, in turn, becomes active(32) through disulphide 
Fig 1.4. The pathway of reoxidation of PDI by Ero1p 
The pathway for reoxidation of reduced PDI by Ero1p initiates with a two-step disulphide 
transfer from the shuttle cysteines of Ero1p (C100/C105) to reduced PDI (Steps 1-3). This 
results in the reoxidation of PDI and reduction of the shuttle cysteines. This induces a 
conformational change in the flexible peptide on which C100 and C105 are situated 
bringing the shuttle cysteines in close proximity with the active site cysteines (C352/C255) 
(Step 4). Through another two-step disulphide exchange the active site cysteines are 
reduced leaving the shuttle cysteines oxidised (Steps 5 and 6). The active site cysteines 
become reoxidised through reduction of FAD, through which the protons are passed to 
molecular oxygen (Step 7). The flexible peptide then returns to the original conformation to 
enable another reoxidation reaction (Step 8). Figure adapted from Sevier, C., et al(23) 
20 
 
transfer from one of the pairs of regulatory cysteines to the active site of the PDI 
molecule hence reducing the regulatory cysteine and enabling activation of 
Ero1p(32).  
Ero1p possesses multiple regulatory disulphide bonds, the first of which to become 
reduced by PDI is the C143-C166 non catalytic cysteine pair, followed by C150-
C295(33) and finally the longest disulphide bond C90-C349(24). This results in a range 
of activation states of Ero1p dependent upon the oxidising conditions and 
abundance of substrate within the ER(33). 
PDI activity is therefore regulated by its requirement, in an excess of substrate PDI 
is required to continually catalyse OPF and therefore Ero1p must remain active to 
catalyse PDI reoxidation. In conditions of scarce substrate PDI is more often in the 
oxidised state and so Ero1p will inactivate through oxidation of the regulator 
disulphide bonds from the active-site cysteines of Ero1p(32). Evidence for this is that 
in mutants containing point substitutions of the shuffle cysteines auto-oxidation of a 
regulatory cysteine from the active-site cysteines can occur(32). 
Ero1p can also be efficiently inactivated by oxidised PDI(32)7KHD¶GRPDLQRI3',
in its partially oxidised state is more able to oxidise the regulatory bonds of Ero1p 
than the a domain in its fully oxidised state(32). Oxidised PDI inactivates Ero1p 
quickly but Ero1p is activated slowly by reduced PDI(32). Such rapid inactivation is 
to be expected as Ero1p needs to respond quickly to an oxidising environment. 
A by-product of Ero1p oxidative activity is the formation of H2O2, a member of the 
reactive oxygen species (ROS) family, which
 
is produced in equimolar amounts for 
each oxidation event Ero1p catalyses(29). H2O2 has both oxidative and reductive 
effects in vivo and can cause damage to a number of vital cellular components such 
as lipids, nucleic acids and proteins(34). A build-up of ROS can therefore have 
detrimental effects upon the cells survival and hence careful control on Ero1p may 
act to regulate ROS build up(24).  
1.1.3 Homologues of protein disulphide isomerase in yeast 
As well as PDI in yeast there are four non-essential ER-located PDI homologues 
whose upregulation in ¨pdi1 mutants can restore viability(4). These are Mpd1p, 
Mpd2p, Eug1p and Eps1p, which share some functional homology with PDI, but are 
expressed in low levels(4). Mpd1p and Mpd2p are the only two homologues that have 
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significant OPF activity, although dramatically decreased compared with PDI(35) and 
hence can restore viability from upregulation, albeit with significant cell defects(4). 
Eug1p and Eps1p instead have roles in isomerisation(4) and ER chaperoning(36), 
respectively. These homologues appear to fill niche roles(37) and therefore a knock-
out of pdi1 may lead to upregulation of one or more of these PDI homologues to 
restore viability(38). 
1.2 Mechanisms of hydrogen peroxide detoxification within the endoplasmic 
reticulum 
1.2.1 Glutathione peroxidases in humans and yeast 
Within the mammalian ER there are 3 known peroxidases that act to detoxify H2O2: 
Peroxiredoxin IV (PRxIV), glutathione peroxidase 7 (GPx7) and glutathione 
peroxidase 8 (GPx8)(39), although at high concentrations of H2O2 PRxIV is 
inactivated(40). In S. cerevisiae, however, there are no obvious ER-localised 
homologues of these proteins(32)(41) suggesting that disulphide bond formation may 
be capped to prevent accumulation of ROS. Yeast contains multiple proteins 
involved in detoxification of H2O2 including 5 peroxiredoxins, a cytosolic catalase, a 
peroxisomal catalase, a mitochondrial resident cytochrome C peroxidase(42), as well 
as evidence for GPx1, GPx2 and GPx3 also being expressed within yeast(43). GPx2 
and GPx3 are localised to the cytosol(44) while GPx1 is localised to the cytosol and 
mitochondria(45). GPx1, GPx2 and GPx3 are in fact phospholipid hydroperoxide 
glutathione peroxidases and are therefore responsible for the repair of the 
peroxidation of membrane lipids(43), the damage of which is a result of the oxidising 
activity of ROS. Presence of these proteins prevent accumulation of ROS as a result 
of other cellular functions in particular the leakage of electrons from the electron 
transport chain within the mitochondria but also as a result of environmental 
stresses(46). None of these proteins, however, are localised to the ER, and therefore 
a regulatory system is in place to control levels of H2O2 production.  
1.2.2 Regulation of hydrogen peroxide production in yeast 
As there are no proteins in yeast that have been identified to directly detoxify H2O2 
in the ER therefore H2O2 accumulation must be prevented through another means. 
Sevier, C. S., et al. have suggested that levels of H2O2 are controlled through 
inactivation of Ero1p(24). As ROS are oxidising agents they oxidise of the regulatory 
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cysteine pairs of Ero1p(24) therefore inhibiting OPF and with it H2O2 production, 
thereby forming a negative feedback loop. Overexpression of a disulphide bonded 
protein in a yeast is therefore limited by this H2O2 regulation mechanism as unlike 
the mammalian ER there are no proteins such as GPx7 and GPx8 that can directly 
detoxify H2O2. 
1.2.3 Glutathione peroxidase 7 
GPx7, also known as NPGPx, is 187 amino acids in length and has a 19 residue N 
terminal cleavable signal sequence that mediates its localisation to the ER and 
retention in the ER lumen(47).  
GPx7 is structurally similar other members of the GPx family, in particularly GPx4(48) 
and is able to catalyse the degradation of H2O2. Despite this similarity the function 
of GPx7 is considerably different to that of other members of the GPx family. One 
distinct difference is that, unlike the other members of the GPx family, with the 
exception of GPx5(49), a catalytically active cysteine is utilised over a selenocysteine 
in GPx7(47). As GPx4 and GPx7 share a common ancestor, there has been a 
substitution of this selenocysteine for the non-selenium containing form(50) during 
divergence of GPx7 from the other members of the GPx family(51). Another key 
difference is that GPx7 is lacking in the loop for GSH specificity(47). This results in 
GPx7 having decreased affinity for GSH but allows for interaction with PDI(47). 
Therefore GPx7 is able to couple detoxification of H2O2 in the ER to the reoxidation 
of PDI.  
GPx7 is expressed in a range of tissue types in mammalian systems(48), allowing for 
ubiquitous detoxification of H2O2  produced in the ER as a result of OPF(29). A 
conserved characteristic of all known members of the human GPx family is the 
catalytic tetrad, this consists of four residues that forms an active site for the 
catalysis of decomposition of H2O2. These conserved residues are the catalytic 
cysteine or selenocysteine, a glutamine and a tryptophan and an asparagine directly 
adjacent to each other in the primary structure of the peptide (Fig 1.5., Fig 1.6.)(52). 
It is suggested that this tetrad enables the hydroxylation of the thiol of the 
catalytically active Cys(52)(53) hence enabling the detoxification of H2O2 and thereby 
making GPx7 an oxidising agent for PDI. In GPx7 these residues are C57, Q92, 




Fig 1.5. Overlay of the structures of the monomeric subunits of GPx4, GPx7 and 
GPx8. 
The structures of overlayed monomeric GPx4(cyan), GPx7(red) and GPx8(green) 
indicating structural similarities between the three proteins. The residues of the catalytic 
tetrad is indicated by yellow text showing the conserved Trp and Asn residue of all three 
peptides as well as Gln(present in GPx7 and GPx8)/Ser(present in GPx8) and Cys(present 
in GPx7 and GPx8)/Sec(selenocysteine present in GPx4). Figure from Maiorino, M., et 
al.(52). 
Relative Position 
     1        10        20        30        40        50        60 
     |        |         |         |         |         |         | 
GPx7 ----------------------MVAATVAAAWLLLWAAACAQQEQDFYDFKAVNIRGKLVSLEKYRG 
GPx8 MEPLAAYPLKCSGPRAKVFAVLLSIVLCTVTLFLLQLKFLKPKINSFYAFEVKDAKGRTVSLEKYKG 
       70        80        90        100       110       120       130 
       |         |         |         |         |         |         |     
GPx7 SVSLVVNVASECGFTDQHYRALQQLQRDLGPHHFNVLAFPCNQFGQQEPDSNKEIESFARRTYSVSF 
GPx8 KVSLVVNVASDCQLTDRNYLGLKELHKEFGPSHFSVLAFPCNQFGESEPRPSKEVESFARKNYGVTF 
          140       150       160       170       180       190       200 








Fig 1.6. Protein sequence alignment of human GPx7 and GPx8  
A comparison of the protein sequence of human GPx7 and GPx8 and the following 
conserved regions of interest identified: the cleavable signal peptide of GPx7(CP)(red), the 
transmembrane domain of GPx8(CP)(blue), the catalytic cysteine of the catalytic tetrad(dark 
green), the remaining three residues of the catalytic tetrad(light green), the auto-oxidative 
cysteine(grey) and the ER retention sequence(pink). 
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As well as having roles in the detoxification of H2O2 GPx7 also has a general role in 
the indirect involvement in reducing intracellular oxidative stress through regulation 
of certain target proteins. One of these proteins is GRP78(54), a 78kDA essential ER 
chaperone which is considered a master regulator of the unfolded protein 
response(55). The formation of a disulphide bond between C86 of oxidised GPx7 and 
either C420 or C41 and induces the formation of the intramolecular C41 to C420 
disulphide bond in GRP78, which increases its affinity for denatured or misfolded 
proteins(54). Therefore in the absence of a reducing substrate for GPx7, as would 
occur under ER oxidative stress, the chaperone effects of GRP78 on misfolded 
proteins are increased.  
1.2.4 Glutathione peroxidase 8 
Less is known about GPx8 than GPx7, but it is a type 1 a transmembrane ER 
protein(47)(56) that is 209 amino acids in length. Unlike the other members of the GPx 
family both GPx7 and GPx8 are ER localised, although resident to the ER lumen 
and transmembrane respectively for GPx7 and GPx8 respectively. It also appears 
to serve a similar function as GPx7 and likely operates by a similar mechanism(47). 
GPx8, similar to GPx7, also is lacking both a loop for GSH specificity and has a 
cysteine rather than a selenocysteine and therefore also has a substrate preference 
of PDI over GSH(47). The catalytic tetrad of GPx8 is similar to that of GPx7, 
possessing a cysteine rather than a selenocysteine but there is a substitution of 
glutamine for serine (Fig1.6.), it is suspected that this substitution does not result in 
any significant changes to the functionality of the protein as serine would still be able 
to accept a proton from the catalytically active cysteine(52). The residues of the 
catalytic tetrad in GPx8 are therefore C79, S114, W164 and N165(52)(Fig 1.6.). 
One key difference between Gpx7 and GPx8 is that GPx8 is an ER transmembrane 
protein. This allows GPx8 to serve a role in preventing passing of Ero1p derived 
H2O2 across the ER membrane and into the cytosol(57). Importantly as both GPx8 
and Ero1p are upregulated in response to ER stress(57), the positive feedback loop 
of increased OPF leading to more ROS generation and therefore further increases 
to ER stress is interrupted by the H2O2 detoxifying effects of GPx8(57).  






1.2.5. Mechanism of hydrogen peroxide detoxification by glutathione 
peroxidases 7 and 8  
Although both GPx7 and GPx8 have very low levels of peroxiredoxin activity with 
GSH, they do have much higher levels of PDI peroxidation with GPx7 having at least 
a 95 times greater activity with PDI as a substrate compared with GSH and GPx8 
has at least 250 times greater activity(47), although there is some dispute regarding 
this finding(50). GPx7 and GPx8 therefore utilise H2O2 to oxidise reduced PDI 
detoxifying H2O2 while also enabling PDI to continue to perform OPF. Despite the 
lower specificity of GPx7 and GPx8 for GSH over PDI there is still competition 
between these two substrates(52) and therefore the rate of PDI oxidation is 
determined by the concentration of GSH. It has been shown that GPx7 and GPx8 
have differing specificities for different members of the human PDI family, with the 
highest activity being in PDI, ERp72 and ERp46 while ERp57 and P5 had lower 
activities(47).  
There are currently two proposed models for the mechanism of GPx7 activity: a 
single-cys-mechanism and a 2-cys-mechanism(39), based on current evidence the 
single-cys-mechanism is the favoured model. In the 2-cys-mechanism it was 
Fig 1.7. Crystal structure of GPx8  
(A) The crystal structure of a molecule of GPx8 absent of transmembrane domain with 
catalytically active cysteine C79 shown in red. Figure adapted from Nguyen, V. D., et al(47). 
(B) Crystal structure of GPx8 in the ER membrane with light green transmembrane domain 





suggested that reduction of substrates was dependent upon an intramolecular 
disulphide bond between C86
 
and C57 within GPx7 that forms in oxidative 
conditions and thereby acting as a sensor for oxidative stress(59). In support of this 
mechanism a disulphide bond was identified between these two cysteines using 
mass spectrometry(59). However, a GPx7C86A mutant exhibited WT like activity 
suggesting the single-cys-mechanism over the 2-cys-mechanism(39), it was also 
demonstrated that the disulphide bond between C86 and C57 is only present in the 
oxidation of GPx7 and when there is an absence of reducing substrate(39). 
The single-cys-mechanism is the current proposed model for both GPx7, it is likely 
that GPx8 operates in a similar way, as both of these proteins have a peroxidatic 
cysteine(CP), C57 for GPx7 and C79 for GPx8(47), but are absent of a resolving 
cysteine(CR)(50) and have closely related amino acid sequence homology (Fig 1.6.). 
The single-cys mechanism suggests that the CP(50) is responsible for both the 
oxidation of H2O2 and the oxidation of PDI, interacting preferably with the a domain 
of PDI(39). The initially reduced GPx7 of GPx8 catalyses the conversion of H2O2 to 
H2O and an ±SOH (sulfenic acid) group attached to CP(39)(50). It is suspected that the 
conserved catalytic tetrad is responsible for enabling hydroxylation of the thiol of CP 
through oxidation of the thiol group by glutamine allowing the formation of sufenic 
acid(52)(53). The liberated proton can interact with the hydroxyl group formed from the 
splitting of H2O2 forming H2O. 
In the presence of a reducing substrate such as PDI or GSH a reduced thiol group 
from either of these substrates interacts with the CP-SOH group yielding H2O and 
forming a disulphide bond between the thiol of the reducing agent and the thiol of 
the CP(39)(50). The next step in the mechanism is a reduction of the CP by a second 
reduced thiol group, in the case of PDI this is from the second cysteine in the CXXC 
domain while in the case of reduction by GSH a second molecule of GSH is used to 
reduce CP(39) (Fig 1.8). This results in formation of the oxidised state of the PDI 
active site which is then able to catalyse OPF, or in the case of GSH reduction a 
molecule of glutathione disulphide (GSSG) is formed(39) (Fig 1.8). This therefore 
couples the detoxification of H2O2 to OPF through the re-oxidation of PDI.  
In the case where there is no available reducing substrates C86 of GPx7(39) or C108 
of GPx8 (Fig1.2) could have a role in generating a stable form of hydroxylated 
proteins in the absence of reducing substrates(39). GPx7 and GPx8s detoxifying 
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effects on H2O2 would lead to increased generation of sulfenic acid (-SOH) due to 
there being no reducing substrates to accept the electrons from reduced GPx7(39) 
and GPx8. The ±SOH group on C57 could therefore react with the ±SH group on 
C86 or C108 for GPx7 and GPx8 respectively. This would yield one molecule of H2O 
and a disulphide bond between C57 and C86 for GPx7 or C79 and C108 for GPx8 
(Fig1.5.). Therefore both C86 and C108 for GPx7 and GPx8 respectively are auto-
oxidative cysteines (CAO). Sulfenic acid is an oxidising agent and can cause 
oxidative damage to either nearby protein or itself if it is not immediately reduced by 
either PDI or GSH, this results in CAO being critical in removing these sulfenic groups 
detoxifying itself(39). Another advantage of this mechanism of action is that in an 
absence of reducing substrate GPx7 and GPx8 are capable of reducing an 
equimolar amount of H2O2 before becoming inactive which would reduce the 
oxidative stress on the ER. The CAO in GPx7 also prevents the formation of 
significantly less active GPx7 homodimers resulting from a disulphide bond bridging 
two C57s(39).  
Fig 1.8. The single-cys model for GPx7 and GPx8 activity with the three suggested 
resolutions of the sulfenic acid produced by H2O2 detoxification. 
A simplified mechanism for the detoxification of H2O2 by GPx7 and GPx8, the initial step 
is conversion of H2O2 to H2O using CP resulting in the thiol of CP becoming hydroxylated 
to a sulfenic acid group (Step1). In order to resolve this sulfenic acid group there are three 
potential pathways. In presence of substrate GPx7 or GPx8 can couple the removal of the 
sulfenic acid group to PDI (Resolution 1) or GSH (Resolution 3) oxidation in a two-step 
process. The first oxidises CP forming a disulphide bond between the target protein and 
CP yielding H2O2. The second step is a reduction event of CP by a second reduced thiol. In 
the absence of utilisable substrate an intramolecular bond can be formed with the auto-




The salvage and detoxification of Ero1p generated H2O2 by GPx7 and GPx8 occurs 
near instantly(39)(57), this is a result of both GPx7 and GPx8 associating with Ero1p 
directly(56). GPx7 and GPx8 bind to the side furthest from the catalytic site and FAD 
cofactor of Ero1p(60) to a region of the peptide containing two regulatory cysteines 
C208 and C241 (Fig 1.9.). This regulatory cysteine pair prevents entry of oxygen to 
the FAD cofactor and GPx7 and GPx8 binding when they are in the oxidised form(61). 
When Ero1p is reduced by PDI, however, this disulphide is broken and hence allows 
entry of oxygen which then can then be reduced to H2O2 by the FAD cofactor(61) (Fig 
1.9.). The breakage of this disulphide bond also allows docking of the GPx8 or GPx7 
proteins(61), which due to its proximity to the site of formation of H2O2 rapidly 
catalyses conversion to H2O and a sulfenic acid group on CP.  
 
 
1.3 Localisation of proteins to the endoplasmic reticulum in yeast  
1.3.1 Endoplasmic reticulum signal sequences 
Nascent peptides that require posttranslational modifications typically enter the ER 
co-translationally and for which require a signal recognition particle (SRP), this 
transports the peptide with associated ribosome to the Sec61 ER membrane 
Fig 1.97KHUHJXODWLRQRI(URĮE\WKH&&F\VWHLQHSDLU 
(QWU\RI R[\JHQ WR WKH)$'FRIDFWRURI(URĮ LV FRQWUROOHGE\D&& UHJXODWRU\
GLVXOSKLGHERQG$,QDEXQGDQFHRIVXEVWUDWH(URĮLVDFWLYHDQGWKH&/C241 cysteine 
pair is reduced, this allows oxygen to accept protons from reduced FAD forming H2O2. 
&& LQ WKH UHGXFHGVWDWHDOVRDOORZVELQGLQJRI*3[DQG*3[ WR(URĮ7KLV
allows rapid degradation of H2O2. B) In the absence of substrate the C208/C241 disulphide 
bond is formed preventing entry of oxygen to FAD and inhibiting GPx7 and GPx8 binding. 




translocon. The nascent protein then enters the ER as it is being translated before 
cleavage of the SRP(62).  
Traditionally a pre-pro secretion signal from the yeast was used for the expression 
of non-native proteins, this consisted of a pre region of a 19 residue signal sequence 
terminating in a peptidase cleavage site followed by the pro region, a 66 residue 
region followed by a Kex2 endoprotease cleavage site and ending in an EAEA 4 
residue peptide, removed by Ste13(63). This sometimes leads to unintended 
products due to incomplete cleavage by Ste13 or Kex2(63).  
Use of an Ost1 pre-VHTXHQFH 0$7Į SUR-sequence hybrid resulted in increased 
efficiency of foreign protein expression, the Ost1 pre-sequence is suitably 
hydrophobic to enable co-translational translocation(63)$GGLWLRQRIWKH0$7ĮSUR-
sequence results in increased export to the ER through binding of the pro-sequence 
to Erv29(63),a chaperone involved in packaging of nascent proteins into COPII 
vesicles for export to the golgi apparatus(64).   
1.3.2 Endoplasmic reticulum retention sequences 
The ER retention of proteins is mediated through their C-terminus, at which the 4 
residue sequence resides: KDEL, among others, for animals(65) while yeast 
exclusively utilises HDEL. The protein responsible for recognition of this HDEL 
sequence is Erd2p, an integral membrane protein with 7 helical transmembrane 
domains(66)(67). The N terminal domain of Erd2p is located within the lumen while the 
C terminal domain is located in the cytoplasm(67). Residues in transmembrane 
domains 1, 2, 5 and 6 are important in facilitating ligand binding and hence it is likely 
that these residues form a hydrophobic pocket, in which the highly polar HDEL 
residue can bind(67). In the human KDEL receptor 4 residues are key in substrate 
binding, Arg5, Asp50, Tyr162 and Asn165 and all are located luminally(66), there is 
likely to be some variation in binding mechanism due to yeast only being able to 
utilise the HDEL tetrapeptide despite the only alteration to that of human KDEL 
sequence is a substitution of the charged residue Histidine for the charged residue 
Lysine. Nonetheless, the Asp50 residue is conserved in all known Erd2 sequences, 
with the exception of in K. lactis(66), it is therefore likely that this contacts the first 
residue of the ER retention sequence(67).  
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Nascent proteins destined for ER retention are first transported into the Golgi to 
allow for post-translational modifications to take place before retrieval back into the 
ER through a salvage compartment on the cis side(68). This occurs through binding 
of the HDEL sequence to Erd2p in the Golgi Apparatus, the receptor:HDEL-protein 
complexes are gathered into COPI coated vesicles and through retrograde vesicular 
protein transport the vesicles dock with the tSNARE Ufe1p with other components 
that enables receptor mediated retrieval of HDEL proteins(69). An Asp193 residue of 
transmembrane domain 7 is required for this retrograde transportation mechanism 
of the receptor-ligand complex(BN).   
1.4 Aims of the project  
The aims of the project was to increase the rate of OPF in S. cerevisiae. As many 
pharmaceutical products require disulphide bond formation in a biological system 
increasing the rate of OPF in yeast would generate an efficient factory at producing 
these biopharmaceuticals. To increase OPF in vivo two main avenues were 
pursued, the first was to investigate a potential mutation that resulted in retained 
YLDELOLW\RID¨pdi1 strain, as this would likely supplement OPF and hence be a key 
target for upregulation to assist disulphide bond formation. Furthermore the 
functions of the yPDI homologues are still largely unknown and so a mutation that 
UHVXOWVLQXSUHJXODWLRQLQRQHRUPRUHRIWKHVHKRPRORJXHVDVDUHVXOWRID¨pdi1 
may shed light upon their function and would form a better model for OPF in yeast 
The second approach was through expression of recombinant GPx7 and GPx8 in 
yeast. As control of levels of ER ROS is dependent upon inactivation of Ero1p(24) it 
is therefore a limiting factor on OPF of high expression proteins, such as 
biopharmaceuticals. The work of Zito, E., has shown that expression of the 
mammalian ER localised PRxIV in yeast can reoxidise yPDI(70). Therefore GPx7 and 
GPx8 may alleviate ROS stress associated with OPF as well as increasing the rate 





Chapter 2 - Materials and Methods 
2.1 Materials 
2.1.1 Yeast and bacterial strains 
2.1.1.1 Saccharomyces cerevisiae strains 
Table 2.1.1.1: Strains of S. cerevisiae used in the project   




2736 0$7ĮDGH-1, ura3-1, leu2-3, 
trp1-1, his3-11, -15, pdi1::HIS3 
+ [GAL1-PDI1-URA3-CEN] 
¨pdi1 genomic 
deletion strain with 
viability maintained 





Cross of 2736 and 
JML3, use of 5FOA 





¨cox4 ¨cox4::HIS Deletion of COX4 
gene encoding 
cytochrome c 
oxidase subunit IV. 
Decreased H2O2 
production removal. 
Ski4  Super secretor of 
killer toxin carrying a 
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mutation in the SKI4 
gene 
S6 Wild type Strain sensitive to 
killer toxin 
 
2.1.1.2 Escherichia coli strains 
Table 2.1.1.2 Strains of E.coli used in the project 
Strains Production 
Z-CompetentTM E.coli cells, DH5Į 
E.coli strain 
Prepared by G. Staniforth (School of 
Biosciences, Kent) using Z-
CompetentTM E.coli Transformation kit 
(G-Biosciences) 
Top 10 Competent E.coli cells, 
commercially available Top 10 
Competent E.coli cells. 
Prepared by E. Kazana (School of 
Bioscience, Kent), competency 






2.1.2 Media Recipes 
All media sterilised in a Classic Prestige Medical (Quirumed) autoclave prior to use.  
Table 2.1.2 Recipes for media used in the project 
Medium Recipe 
YPD 2% D-Glucose Anhydrous, 1% Yeast 
Extract, 2% Bactopeptone, (+2% Agar 
for solid medium) 
Synthetic Defined Drop Out Medium 2% D-Glucose Anhydrous, 0.67% YNB 
w/o amino acids, 0.16%(-Leu) / 
0.195%(-Ura) / 0.155% (-Leu ±Ura) 
Synthetic Complete Drop-Out Mixture, 
(+2% Agar for solid medium) 
5FOA Medium 2% D-Glucose Anhydrous, 0.67% YNB 
w/o amino acids, 0.2% Complete SC 
Mixture, 5FOA added by filter 
sterilsation to a final concentration of 
5.74mM post autoclaving and once 
PHGLXP KDG FRROHG WR aÛ& 3ODWHV
stored at 4Û& 
LB with Ampicillin 1% Tryptone, 0.5% Yeast Extract, 1% 
NaCl, (+2% Agar for solid medium) and 
autoclaved. For solid medium ampicillin 
added to a final concentration of 
100µg/ml once medium had cooled to 
aÛ& )RU OLTXLG PHGLXP DPSLFLOOLQ
added to a final concentration 100µg/ml 




Prior to plating cells onto agar plates they were dried in a drying oven for ~10 min 
DWaÛ& 
2.1.2.1 Making killer toxin assay solid medium 
2.1.2.1.1 Base Agar 
0.5% (w/v) Yeast Extract, 0.5% (w/v) Bactopeptone, 1.5% (w/v) Agar, 0.05M Citric 
Acid and 0.1M Na2HPO4 in 90% of total intended volume distilled water (dH2O), 
adjusted to pH 4.6-4.8 with HCl and then autoclaved. 4% D-Glucose Anhydrous 
added by filter sterilisation post autoclaving and oncHPHGLXPKDVFRROHGWRaÛ&
filter sterilised Methylene Blue added to a final concentration of 0.375mM. 20mL 
added to each 8.5cm diameter plate and left to solidify. 
2.1.2.1.2 Top Agar 
Made in an identical fashion to Base Agar but without the addition of methylene blue. 
O/N culture of S6 yeast strain diluted to OD600 0.1 and regrown to OD600 0.4-0.5 and 
added to Top Agar to a cell density of 5x106 cells/ml. ~5ml of Top Agar poured over 
solidified Bottom Agar giving a total plate media volume of ~25ml of Killer Toxin 
Assay agar. Made on day of assay. 
2.1.3 Chemicals used  
Table 2.1.3 A list of chemicals used the project and their manufacturer 
Chemical Used in Media Manufacturer 
D-Glucose Anhydrous Fisher Scientific 
Yeast Extract Fisher Scientific 
BactoTM peptone Fisher Scientific 
Granulated Agar Fisher Scientific 
YNB w/o Amino Acids Fisher Scientific 
Synthetic Complete Drop-Out Mixtures Formedium 




2.1.4 Oligonucleotide sequences 

















Citric Acid Sigma-Aldrich 
Na2HPO4 Sigma-Aldrich 
Methylene Blue Sigma-Aldrich 




All oligonucleotides were designed during this project and produced by Eurofins 
Genomics, for more information see section 2.2.10. 
2.1.5 Antibodies used 
Table 2.1.5 The suppliers of the antibodies used during this product and the 
dilution at which they were used 
Antibody Supplier Dilution 
Yeast PDI Antibody made Capra 
Sciences against antigen 
purified by Beal, D. M. 












Yeast PGK Antibody made by York 
Biosciences against 
purified PGK1 purchased 
from Sigma Aldrich 
1/5000 







Sigma Aldrich 1/5000 
Anti Mouse IgG-
Peroxidase 






2.1.6 Plasmids used 
Table 2.1.6 The name and details of plasmids used during this project 
Plasmid 
Name 





GPx7 with signal 
sequence (residues 2-19) 
replaced with 6xHis Tag. 
¶Kpn,DQG¶SacI 
restriction sites. 




¶SacI restriction sites 












6676 This Project 
pUKC3404 pTH644-L 
CEN 
GPx7 with original human 
leader sequence with HA 
tag and Yeast ER 
retention signal 
~7494 This Project 
pUKC3405 pTH644-L 
CEN 
GPx8 with original human 
leader sequence with HA 
tag and Yeast ER 
retention signal 
~7560 This Project 
pUKC3406 pTH644-L 
CEN 
GPx7 with Yeast Ost1 
pre-sequence and Yeast 
MAT pro-sequence with 
~7584 This Project 
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GPx8 with Yeast Ost1 
pre-sequence and Yeast 
MAT pro-sequence with 
HA tag and Yeast ER 
retention signal 







GPx7 with signal 
sequence (residues 2-19) 
replaced with 6xHis Tag 
~4200 Ruddock, L 
(Biocenter Oulu 




















Killer Toxin 7995 - 
GLuc 
Plasmid 
pBEVY-U Gaussia Luciferase with 
pre-pro MATĮ factor for 
intracellular localisation 







2.1.6.1 Cloning vector maps  
  
Fig 2.1. Plasmid map of p6431 
Plasmid map of p6431 plasmid for GFP fusion, sites of interest including the CUP1 
promoter and sGFP ORF included as well as restriction sites. The previously second 
XbaI restriction site present in the CUP1 promoter is shown in red. Map from Serio, T. 





Fig 2.2. Plasmid map of pBEVY-L 
Plasmid map of pBEVY-L plasmid backbone(71) for native GPx7 and GPx8, the gene 
insert site for which is shown in red. AmpR, GAP and lac promoter regions,  selection 
markers AmpR and LEU2, ADH1 and ADH2 terminators and 2µ origins shown in dark 







All plasmid maps were made using ApE, A Plasmid Editor, software by Davis, M. 
W., (Deparment of Biology, University of Utah).  
Fig 2.3. Plasmid map of pTH644-L 
Plasmid map of pTH644-L plasmid backbone(72) for GPx7 and GPx8 constructs, the 
gene insert site for which is shown in red. AmpR, GAP and lac promoter regions,  
selection markers AmpR and LEU2, ADH1 and ADH2 terminators and CEN/ARS 
origins shown in dark grey. Common restriction sites of the vector shown.  
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2.2 DNA techniques 
2.2.1 DNA extraction from E.coli 
A QUIprep Spin Miniprep Kit (Quigen) was used to extract plasmid DNA from E.coli 
as per the protocol supplied by the manufacturer. RNA was degraded through 
addition of RNAse prior to lysis using an alkaline based buffer. Successful lysis was 
confirmed through a colour change of sample using LyseBlue (Quigen). The sample 
was then neutralised using guanidine hydrochloride and adjusted to high salt 
content with potassium acetate(73) to facilitate DNA binding to a QuiaPrep silica gel 
membrane. Salts are washed from the DNA sample bound to the gel silica 
membrane with a solution of 70% ethanol with Tris-HCl, the DNA was then eluted 
using 50µL 10mM Tris-Cl and stored at -20ÛC 
2.2.2 Extraction of genomic DNA from yeast 
Using a Epicentre Masterpure Yeast DNA purification kit genomic DNA extracts of 
yeast cultures were prepared, as was performed as per the manufacturers protocol. 
A S. cerevisiae culture grown for 16-18hr shaking incubation at 30ÛC was pelleted 
at 13,000RPM and resuspended in Yeast Lysis Buffer (Epicentre) and incubated at 
65ÛC for 15 min. Protein was precipitated from the DNA sample using MPC Protein 
Precipitation Reagent (Epicentre) and pelleted along with cellular debris. DNA 
containing supernatant was removed and precipitated using isopropanol, the DNA 
was pelleted and washed in 70% ethanol before resuspension of the DNA in 30 TE 
µL buffer (10mM Tris-HCl, 1mM disodium EDTA) and stored at -20ÛC. 
2.2.3 Methods of quantification of DNA concentrations 
2.2.3.1 NanoDrop 
The OD260/OD280/OD230 of DNA samples were measured using a NanoDrop 
Microvolume Spectrophotometer. A 2µL volume of each sample was measured 
against an elution buffer blank. 
2.2.3.2 Spectrophotometry 
DNA samples were diluted 50-fold in MilliQ H2O in a UV Cuvette (BrandTech 
Scientific, Inc.) and OD260/OD280 measured. Likewise the elution buffer was diluted 
50-fold with MilliQ H2O and was used as the blank. 
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2.2.3 E.coli transformation with plasmid DNA 
2.2.3.1 Z-CompetentTM E.coli cells 
Z-CompetentTM E.coli Cells prepaed by G.Staniforth (School of Biosciences, Kent) 
and stored at -Û&ZHUHGHIURVWHGRQLFHDQG/RISODVPLG'1$DGGHGWRHDFK
20µL sample. The samples were mixed and left for 5 - 15 min on ice before plating 
onto LB + Ampicillin plates and incubated overnight (~16-KUDWÛ& 
2.2.3.2 Top10 E.coli cells 
Top10 E.coli Cells prepared by E.Kazana (School of Biosciences, Kent) were 
thawed on ice from a -Û&VWRFN/RISODVPLG'1$ZDVDGGHGWRD/ aliquot 
and left on ice for PLQ&HOOVZHUHWKHQKHDWVKRFNHGDWÛ&IRUVHFSXWEDFN
on ice for 2 min for recovery and then 900µL of LB medium was added to the aliquot 
DQG LQFXEDWHG IRU  KU DW Û&  / RI WKH VDPSOH ZDV SODWHG RQWR WKH
LB+Ampicillin agar and incubated overnight (~16-KUVDWÛ& 
2.2.4 Yeast transformation 
 A yeast culture grown in YPD medium for ~16-KUVLQDVKDNLQJLQFXEDWRUDWÛ&
was pelleted, the supernatant was removed and resuspended in 240µL 50% PEG 
(Sigma Aldrich), 36µL 1M LiAc, 34µL dH2O, / VV'1$  / 0 ȕ-
mercaptoethanol (Sigma Aldrich) and ~0.25µg plasmid DNA. Samples were then 
LQFXEDWHGIRUPLQDWÛ&DQGWKHQIRUDIXUWKHUPLQDWÛ&7KHFHOOVZHUH
pelleted at 2000 rpm for 5 min, the supernatant removed and the cell pellet 
resuspended in 100µL in sterile dH2O(sdH2O) and plated onto solid selective 
medium (table2.1.2). Culture grown for ~3-GD\VDWÛ&DQGFRORQLHVUHSODWHGRQWR
fresh selective medium before use. 
2.2.5 Standard polymerase chain reaction 
Polymerase chain reactions (PCR) was performed with Taq polymerases from either 
from New England Biolabs® Inc. (NEB) or Invitrogen were used and hence 
conditions specific to these enzymes were needed. For both enzymes a Bibby 





2.2.6.1 NEB Taq polymerase 
The reaction mix for a PCR reaction using the NEB OneTaq Hot Start DNA 
polymerase was: 
x 5µl 5x standard taq reaction buffer 
x OP0G173¶V 
x 0.5µl 100µM forward primer 
x 0.5µl 100µM reverse primer 
x ~0.2µg target DNA 




x H[WHQVLRQÛ&IRUPLQNEIROORZHG by  
x DILQDOH[WHQVLRQVWHSÛ&IRUPLQ 
2.2.6.2 Invitrogen Taq polymerase 
The reaction mix for a PCR reaction using the Invitrogen Taq polymerase was: 
x 2.5µl 10x PCR buffer minus Mg2+,  
x 0.5µl 10mM dNTP mixture,  
x 0.75µl 50mM MgCl2,  
x 0.5µl 10µM forward primer,  
x 0.5µl 10µM reverse primer,  
x ~0.2µg target plasmid DNA  
x 18µl MilliQ H2O to make a ~25µl reaction mix.  
The thermocycling conditions used were: 
x LQLWLDOGHQDWXUDWLRQÛ&IRUPLQ 
x 25-F\FOHVRIGHQDWXUDWLRQÛ&IRUVHF 






2.2.7 Gradient polymerase chain reaction 
PCR reaction mixes were prepared as described above but using a BioRad C1000 
ThermoCycler PCR to carry out the reactions. All reactions were performed 
simultaneously with different annealing temperatures to identify the optimal 
conditions for amplification. Annealing temperatures set provided 8 different 
WHPSHUDWXUHSRLQWVLQDUDQJHRIÛ&IURPÛ&WRÛ& 
2.2.8 Agarose gel electrophoresis 
A 1% (w/v) agarose (Melford) solution in 1 x TAE (40mM Tris Base, 1mM EDTA, 
4mM acetic acid)  was microwaved for ~1 min to dissolve the agarose and left to 
FRRO WR aÛ& 6\EU6DIH '1$ VWDLQ ,QYLWURJHn) was then added to a final 
concentration of 0.002% (v/v). The solidified agarose gel was then transferred to a 
gel tank and submerged in 1 x TAE. DNA Gel Loading Dye (6x) (ThermoFisher 
Scientific) was added in a 1:5 ratio to DNA samples, 6µl of which was then loaded 
into the agarose gel wells, gel run at 80-100V until the dye front was ~2cm from gel 
end. Gels were then imaged using a Syngene G:Box using blue light excitation of 
the SybrSafe dye at a 500nm wavelength. Images were captured using GeneSys 
software. 
2.2.9 Restriction Enzyme Digests 
~0.2µg of plasmid DNA or ~0.2µg of PCR product was incubated with 1µL of each 
fast digest restriction enzyme (ThermoFisher Scientific) required with 10x fast digest 
buffer diluted to 1x and made up to 20µL (for plasmid DNA) or 30µL (for PCR 
products) with nuclease-free H2O. Restriction digest mixes incubated at 37ÛC for 20 
min.  
2.2.10 Oligonucleotide primer design 
Oligonucleotide primers were designed complying with the following specifications 
wherever possible: 40-60% GC content, 18-30 nucleotides long and Tm RIÛ&WR
Û&DQGZLWKWKHIRUZDUGDQGUHYHUVHSULPHUVKDYLQJ7m ZLWKLQÛ&RIHDFKRWKHU
Hairpin formation, complementarity and self-annealing regions were avoided. The 





2.2.11 Plasmid construction 
PCR-generated DNA products were double restriction digested along with the target 
plasmids. Any small oligonucleotides released from these restriction digests were 
removed using a PCR purification or Agarose Gel purification kits (i.e. ThermoFisher 
Scientific GeneJET PCR Purification Kit or GeneJET Gel Extraction Kit respectively, 
performed as per kit protocol). The DNA concentration of these linear target 
plasmids and inserts with cohesive ends was quantified (see 2.2.3). For the ligation 
reaction 10-100ng of vector DNA was typically used and the insert mass required in 
the ligase reaction was determined using the following calculation:  ܫ݊ݏ݁ݎݐܯܽݏݏሺ݊݃ሻ ൌ  ?ݔ ܫ݊ݏ݁ݎݐܮ݁݊݃ݐ݄ሺܾ݌ሻܸ݁ܿݐ݋ݎܮ݁݊݃ݐ݄ሺܾ݌ሻ ݔܸ݁ܿݐ݋ݎܯܽݏݏሺ݊݃ሻ 
The insert and vector DNA at the calculated masses was incubated with 4µl of 5x 
Rapid Ligation Buffer and 1µl T4 DNA ligase (5U/µL) from a ThermoFisher Scientific 
kit and nuclease-free H2O added up to 20µl final volume. Each ligation mix was 
LQFXEDWHGDWÛ&IRUPLQ$FRQWUROZDVUXQDORQJVLGHHDFKOLJDWLRQUHDFWLRQLQ
which no DNA insert was added to the mix to determine the level of vector 
recircularization without insert inclusion. 
2.3 Protein techniques 
2.3.1 Cell lysates 
Overnight (~16-18hrs growth) cell cultures were diluted in fresh medium to OD600 
0.1 and regrown for ~4hrs to OD600 ~0.5. The log phase cells were then pelleted, 
the medium removed and the cell pellet washed in 1 ml ice cold sdH2O prior to 
resuspension in 200µL lysis buffer (100mM NaOH, 50mM EDTA, 2% (v/v) SDS, 2% 
YYȕ-mercaptoethanol) (Sigma-Aldrich), prepared on day of lysis. The sample was 
WKHQERLOHGDWÛ&IRUPLQ/0DFHWLFDFLG)LVKHU6FLHQWLILFDGGHGDQG
the VDPSOHERLOHGDJDLQDWÛ&EHIRUHDGGLWLRQRI/EOXHEXIIHUP07ULV
HCl pH 6.8, 50% (v/v) glycerol, 0.05% Bromophenol Blue (Fisher Scientific) and 




2.3.2 Protein precipitation from culture medium 
2.3.3 Protein gel electrophoresis 
NuPAGETM 4-12% Bis-Tris 10 wells Gels (ThermoFisher Scientific)were used for 
protein gel electrophoresis with 1 x NuPAGETM MOPS SDS running buffer (50mM 
MOPS, 50mM Tris Base, 0.1% SDS, 1mM EDTA, pH 7.7). 5µL of PageRuler 
Prestained Protein Ladder (ThermoFisher Scientific) was loaded into lane 1, 10µL 
of each sample was loaded into remaining lanes using gel loading tips. 180V was 
applied to the gel and run until the dye front had reached the bottom of the gel. The 
gel cassette was opened, well dividers removed and membrane removed to be 
transferred to PVDF membrane. 
2.3.4 Western blot 
2.3.4.1 Transfer 
An Invitrogen Semi-Dry Blotter was used for the transfer of proteins from the SDS-
PAGE onto a PVDF membrane. The PVDF membrane was cut to 7.5cm by 8.5cm: 
the size of the SDS-PAGE gel. The membrane was then soaked in pure methanol 
(Thermo Fisher Scientific) for 2 min before being rinsed in dH2O and then placed 
into 1x NuPAGETM Transfer Buffer (ThermoFisher Scientific)  with the SDS-PAGE 
gel for 10 min. The transfer stack consisted of 5mm transfer paper on the top and 
bottom sandwiching PVDF membrane beneath the SDS-PAGE gel. The blotter was 
run for 45 min at 20V.  
2.3.4.2 Imaging 
After transfer, the PVDF membrane was then placed in 10mL of 5% Oxoid skim milk 
solution in PBS (Oxoid) to block for 30 min. The milk solution was then removed and 
10ml of 5% Oxoid skim milk solution in PBS with primary antibody diluted to the 
PDQXIDFWXUHU¶VVXJJHVWLRQZDVWKHQDGGHG7KLVZDVSODFHGRQWRDEHOO\GDQFHU
shaker overnight (~16-KUVDWÛ&,IDQ+53FRQMXJDWHZDVXVHGWKHPHPEUDQH
was washed thrice in 10ml of PBS for 10 min per wash before exposure. If a 
secondary antibody was required then peroxidase-conjugate secondary antibody 
with specificity to the primary antibody in 5% Oxoid skim milk PBS solution diluted 
WRPDQXIDFWXUHU¶VVXJJHVWLRQZDVDGGHGDQGLQFXEDWHGIRUKUDWURRPWHPSHUDWXUH
on a belly dancer shaker. Solution 1 (4.3ml dH2O, 0.5ml 1M Tris pH 8.5, 50µl luminol 
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[Sigma-Aldrich] and 22µl p-Coumaric Acid) and solution 2 (4.5ml dH2O, 0.5ml 1M 
Tris pH 8.5, 3.2µL 30% H2O2)  were prepared in 15mL falcon tubes and stored 
wrapped in aluminium foil to protect these light sensitive solutions from exposure.  
The solution present on the membrane was poured off and solution 1 and solution 
2 of the ECL solution combined and poured onto membrane and agitated gently for 
1 min. The membrane was then removed with tweezers from the solution and placed 
on the inner plastic sleeve of the exposure cassette. The outer plastic sleeve was 
placed on top of the membrane and Amersham Hyperfilm ECL (18x24cm) placed 
on top of plastic sleeve. The cassette was fastened shut for the duration of the 
exposure before running the film through the Optimax 2010 Film Processor.  
An alternate method of imaging western blots was also used i.e. using a Syngene 
G:Box with GeneSys Software. 
2.4 In vitro oxygen consumption assay  
A Digital Model 10 oxygen electrode (Rank Brothers Ltd) was used to assay for 
ambient levels of oxygen within a sample (Fig 2.4.). A water circulator was used to 
KHDWWKHFHOOFRQWDLQLQJWKHR[\JHQHOHFWURGHWRÛ&ZLWKDQLQLWLDOKHDWLQJSHULRG
RI  PLQ EHLQJ XVHG WR HQVXUH WKH FHOO ZDV PDLQWDLQHG DW D FRQVWDQW Û& $
saturated KCl solution was added onto the electrode with PTFE film placed over the 
top and sealed. Polarising volts were adjusted to 0.6V and the electrode reading 
adjusted to zero before the electrode was plugged in and the magnetic stirrer added. 
$Q(OPDQ¶VDVVD\ZDVSHUIRUPHGRQ*6+ to assay for levels of free thiols(75) from 
which the volume of GSH required to reach a final concentration of 40mM free thiol 
GSH could be calculated. The reaction mix was as follows: 
x O2 Buffer (100mM Tris, 50mM NaCl, pH 8),  
x 5µM PDI 
x 10µM Ero1p  
x 50µM GPx7 or 50µM GPx8 when required  
x dH2O added to give a final volume of 600µL per reaction.  
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Each reaction mix was added to the oxygen electrode cell and magnetic stirrer 
turned on and left until the electrode reading stabilised. At this point the electrode 
reading was adjusted to 100 and electrode reading recording started. After 100 sec 
12µL Ero1p (Pg) was added and the reaction left to continue until after rate of 
consumption of oxygen had begun to decline. Using PicoLog data logging software 
a graph was generated of the ambient levels of oxygen in the system with time, from 
which the rate of oxygen consumption was calculated. 
2.5 Yeast techniques 
2.5.1 Spontaneous generation of ¨pdi1 mutants 
A cell count was performed on a culture yeast strain 2736 after overnight growth 
(16-18hrs) using a haemocytometer to determine cell density. To establish the rate 
RIVSRQWDQHRXVPXWDWLRQJHQHUDWLQJYLDEOH¨pdi mutants, ~8x105 cells were plated 
onto 5FOA plates (table 2.1.2) and incubated for ~10 days at 30ÛC.  
 
 
Fig 2.4. Diagram of components of the oxygen electrode used for the 
oxygen consumption assay 
The externally visible set up (A), and deconstruction of components (B) of the 
oxygen electrode. Key components indicated including the sample chamber, 
water cooling system and electrode base Image (B) from manufacturers website 





2.5.2 Generation of ¨pdi1 mutants through mutagenesis 
This was performed identically to 2.4.1, however, the resulting plates were then 
exposed to 30µW/cm2 of radiation for 20 sec prior to incubation. The dosage was 
determined using a radiometer. All agar plates were then wrapped in aluminium foil 
to prevent exposure to light which could induce photoreactivation and hence result 
in DNA repair(76).  
2.5.3 Producing -Û&JO\FHUROVWRFNV 
0.5ml of an overnight (~16-18hrs) YEPD-based culture of yeast was added to 0.5ml 
50% glycerol, mixed thoroughly and added to a 1.8ml Nunc® CryoTube cryogenic 
vial and stored at -Û&:KHQUHTXLUHGDVPDOOSRUWLRQRIWhe frozen sample was 
removed without defrosting and added to suitable agar plate or liquid medium to 
prevent multiple freeze thaw cycles of the cell stock. 
2.5.4 Measuring growth in liquid medium 
Overnight cultures (~16-18hrs) were diluted to OD600 ~ 0.1 and a volume consistent 
for all samples to be measured was then transferred to a sterile 96 well microwell 
plate. Where required a drug was added to each sample to the required final 
concentration. Absorbance at OD600 ZDV PHDVXUHG IRU a GD\V DW Û& XVLQJ a 
SPECTROstar Nano Microplate Reader (BMG Labtech) with double orbital shaking.  
2.5.5 Spectrophotometry 
1ml of a culture was added to a Sarstedt polystyrene and acrylic 1ml cuvettes and 
the OD600 measured. If the absorbance reading was higher than 1.0 the culture was 
diluted with identical sterile medium to give a reading less than 1.0. 
 
2.5.6 Replica plating  
Yeast cultures were diluted with appropriate liquid medium to OD600 0.1. 100µl of 
culture was added to different wells of a sterile 96-well microwell plate, a sterile 
replica plater was placed into the wells and agitated for a few sec before being 
transferred to an agar plate dependent upon the assay where the replica plater was 
moved in a small circular motion on the surface of the agar plate to ensure complete 




2.5.7.1 Cell counts using a haemocytometer  
A sample of a culture was added to a haemocytometer to completely cover both 
grids before the cover slip replaced. Five 62.5µm squares were counted in each grid 
and the average taken to estimate the cell numbers/mL in the culture. If the cell 
density was too high to count, the culture was diluted by a factor of 10 in sdH2O and 
recounted. 
2.5.8 Fluorescence analysis of cells by flow cytometry 
Overnight cultures (~16-18hrs) were diluted to OD600 ~ 0.5 in sdH2O, pelleted and 
transferred to appropriate fresh medium with or without 2mM H2O2 and incubated at 
Û& IRU  KUV 7KH PHGLXP ZDV WKHQ UHPRYHG DQG FHOOV ZDVKHG EHIRUH
UHVXVSHQVLRQ LQ <3' ZLWK RU ZLWKRXW 0 ¶ ¶-dichlorodihydrofluorescein 
diacetate (H2DCFDA) and incubated for a further 3 hr. 10µl of the sample was then 
added to 1ml of PBS in a BD Falcon 5ml Polystyrene Tube and attached to the 
sample injection port (SIP) of the flowcytometer (Fig 2.5). Cell fluorescence was 
measured through excitation of cells at 490nm and detection through an emission 
at 517-527nm by the primed fluorescent H2DCFDA dye. A histogram plot of cellular 
fluorescence and a dot plot of forward and side scatter were generated using BD  
CellQuestTM Pro Analysis software. The basal fluorescence was established by 
adding a line at which ~50% of the cells were more fluorescent and ~50% of the 
cells were less fluorescent on the histogram for culture incubated in the absence of 
H2DCFDA dye(Fig 2.6.). The change in the percentage of the population of more 
fluorescent cells as a result of addition of H2DCFDA was measured (Fig 2.6.). 
2.5.9 Killer toxin assay 
Strains transformed with pVT100U-K1 plasmid were grown overnight (~16-18hrs) in 
selective medium and diluted to OD600 0.2 before regrowth in fresh selective medium 
to OD600 0.7-0.8. All cell cultures were adjusted to this OD600 with sdH2O. Cultures 
added in 20µl aliquots to sterile Grade AA 6mm Whatman discs placed on Killer 
7R[LQ$VVD\DJDUVHH&XOWXUHVZHUH LQFXEDWHGDWaÛ&RYHUQLJKW -
18hrs), the area of the zones of clearing around the 6mm Whatman discs formed as 






cells within the 
M1 region (%) 
Percentage of 
cells outside of 
M1 region (%) 
50.1 49.9 
Percentage of 
cells within the 
M1 region (%) 
Percentage of 
cells outside of 
M1 region (%) 
22.9 77.1 
Fig 2.6. Histogram of flow cytometry to show change in percentage of 
fluorescent cells from as a result of addition of H2DCFDA dye 
The M1 region set to contain 50% of the cells of the population to determine basal 
levels of fluorescence (A1)(A2). As a result of addition of H2DCFDA there is a shift in 
increase in percentage of fluorescent cells in the population which can be seen by shift 
of the hisogram (B1), the change in percentage of cells outside of the M1 region from 
the basal levels of fluorescence can therefore be measured to calculate change in 
percentage of fluorescent cells in the population (A2)(B2). 
Fig 2.5.  Sample Injection Port of the flow cytometer 
1ml of PBS and culture in a BD Falcon 5ml Polystyrene Tube is held in place by the 






Chapter 3 ± Results 
3.1 6FUHHQIRUYLDEOH¨pdi1 mutants 
As PDI1 is an essential gene in yeast a knock-out of this gene ordinarily results in 
cell lethality(4). Therefore if a strain remained viable following a PDI1 knock out it 
ZRXOGLQGLFDWHDVXSSUHVVRURI¨pdi1 lethality, termed supX. The mutation supX is 
suspected to be upregulation of one of the nonessential yPdi1p homologues, Mpd1p 
RU0SGSDVWKHVHKDYHEHHQVKRZQWREHDEOHWRUHVWRUHYLDELOLW\WR¨ pdi1 strains(4). 
7KHUHIRUHYLDEOH¨pdi1 strains are to be created and the supX mutation identified. 
Selection for 2736 strain that had lost the PDI1 URA3 plasmid was performed using 
5-FOA(77) and hence select for YLDEOH ¨pdi1 strains of yeast. The URA3 gene 
encodes for a protein called orotidine-¶-monophosphate decarboxylase 
(ODCase)(78), this converts orotidine-¶-monophosphate (OMP) to uridine-¶-
monophosphate (UMP) which is then utilised for RNA production(79). 5-FOA is an 
OMP homologue and is converted to 5-FU by ODCase and orotate 
phosphoribosyltransferase (OPRTase), 5-FU can be misincorporated into DNA and 




Fig 3.1. The possible fates of 2736 strain yeast plated onto 5FOA 
When the URA3 PDI1 plasmid carrying strain 2736 is plated onto 5-FOA there were three 
possible proposed outcomes. If the cell retains the plasmid is dies due to conversion of 5-
FOA to the toxic compound 5-FU by ODCase, if the cell loses the plasmid but does not 
have the supX mutation it dies througK¨pdi1 lethality. Only if the cell has both lost the 
plasmid and has supX mutation does it survive to form a colony on 5-FOA plates. 
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Colonies of 2736 strain yeast that emerge following plating onto 5-FOA medium 
VKRXOGWKHUHIRUHEH¨SGL¨XUD and supX as any cells that retain the plasmid will 
be killed by the conversion of 5-FOA to the toxic compound 5-FU. Strains that have 
lost the plasmid but do not have supX ZLOOEHNLOOHGE\¨pdi1 lethality.  
3.1.1 Duration of ultraviolet radiation exposure for a 50% kill rate 
 
7R LQFUHDVHWKHIUHTXHQF\RIYLDEOH¨pdi1 mutants UV mutagenesis was used to 
increase the rate of mutation. UV causes mutations by UV photons are absorbed by 
the double bonds of pyrimidines, resulting in their breakage, if two adjacent 
pyrimidines are hit by UV light they are able to dimerise through reformation of the 
broken disulphide bonds forming a cyclobutane ring connecting the two 
nucleotides(80)(81). This nucleotide dimer is misincoporated as a single nucleotide 
during DNA replication resulting in frame-shift mutations. To find a 50% kill rate and 
therefore an appropriate induction of mutation without excessive cell lethality(82)  
~100 colony forming units (CFU) were exposed to 30mW/cm2 UV radiation for 0s 
to 40s in 10s intervals performed in triplicate. A line of best fit was used to indicate 
that the duration of UV exposure that resulted in a ~50% kill rate was ~20s (Fig 3.2.). 
Fig 3.2. Colony count on YNB-Ura as a result of exposure to a 
range of durations of UV exposure.  
~100 CFUs of 2736 strain yeast on YNB-Ura solid medium were 
exposed to a range of durations of 30mW/cm2 UV radiation from 0s to 
40s in 10s intervals followed by 3 days incubation. The number of 
colonies at each exposure were counted and plotted, the resulting line 



























This duration of UV exposure was used in all subsequent mutagenesis events to 
generate ¨pdi1 strains. 3RWHQWLDO¨SGLPXWDQWVHPHUJHGRQ-FOA solid medium 
through either spontaneous generation, a mutation rate of ~1.9x10-6, or through UV-
induced mutagenesis, at a mutation rate of ~4.3x10-6, and were replated onto fresh 
5-FOA solid medium to confirm absence of 5-FOA-mediated cytotoxicity. 
*URZWKRISRWHQWLDOYLDEOH¨pdi1 mutants on YNB±Ura solid medium 
Growth on 5-FOA should result in selection for ¨ura3 strains, to confirm this cell 
suspensions of putative ¨pdi1 mutants were inoculated on YNB±Ura solid medium 
to confirm lack of growth as a result of loss of the PDI1-containing plasmid. Initially 
3 mutants generated through mutagenesis (designated PDIMR2-PDIMR4) and 5 
mutants spontaneously generated (designated PDISR2-PDISR7) were tested on 




All but 2 strains, PDISR5 and PDISR6, were able to grow i.e. were Ura+ with little 
to no impediment of growth on YNB-Ura medium (Fig 3.3.).  Peculiarly, DN5, a 
homozygous ura3/ura3 diploid heterozygous strain with both reverting ¨ura3-1(83) 
and non-reverting ¨ura3-52(83)(84) alleles, was also able to grow on YNB-Ura (Fig 
3.3). As YNB±Ura plates from the same batch had been used for other purposes 
confirming that the medium was not defective, a fresh stock culture of DN5 was 
made. 
A further 12 mutants (PDIMR17, PDIMR19 and PDIMR21-30) were obtained after 
UV mutagenesis in identical fashion to those prior. This was to screen enough viable 
5-FOA resistant mutants to find a successful ¨ pdi1 supX mutant and to be confident, 
if no successful ¨pdi1 mutants are found, that it is due to supX not being a mutation 
)LJ*URZWKRISRWHQWLDO¨pdi1 mutants on YNB-Ura 
solid media 
/RIFXOWXUHVRISRWHQWLDO¨pdi1 mutants PDIMR2-4, 
PDISR2 and PDISR4-7 at OD600 0.1 were added to YNB-
Ura medium as well as to 5-FOA as a growth control.  
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that can occur rather than from small sampling numbers.  These mutants were 




plated cells, suggesting reversion of the ura3-1 mutation in the 2736 strain (Fig 3.4.). 
This occurred at a much higher frequency than seen with the ura3-1/ura3-52 diploid 
DN5. Growth on YNB-Ura also occurred at much lower rate than mutants PDIMR2-
4, PDISR2 and PDISR4-7 (Fig 3.3), however, this may have resulted from addition 
of 5µL of OD600 0.1 culture resulting in a much higher CFU number being added 
than through replica plating. 
Therefore, as there is papillae growth of PDIS/MRx mutant on YNB-Ura medium, it 
suggests that the ura3-1 mutation of the PDIS/MRx mutants is able to revert to 
URA3 at a much higher frequency than that of DN5.  
3.1.3 Assaying for absence of protein disulphide isomerase in the potential 
¨pdi1 mutants 
Despite growth of PDIS/MRx mutants on YNB-Ura it appears that the mutants are 
reverting to the WT URA3 gene, and hence may still have lost the URA3 plasmid, 
and with it PDI1. Therefore in order to determine wheWKHUSRWHQWLDO¨SGLVWUDLQV
were still expressing yPdi1p a western blot was performed. 
)LJ*URZWKRISRWHQWLDO¨pdi1 mutants on YNB-Ura 
solid media 
&XOWXUHVRISRWHQWLDO¨pdi1 mutants PDIMR17,19 and 
PDIMR21-30 at OD600 were added to YNB-Ura medium via 




DN5. Purified yPDI, a gift from Beal. D.M. (School of Biosciences, Kent) and Pdi1p 
positive control cell extracts (a gift from G. Staniforth, School of Biosciences, primary 
antibodies for yPdi1p and phosphoglycerate kinase (PGK), the latter as a loading 
control. 
7KHLQLWLDOFROOHFWLRQRISRWHQWLDO¨pdi1 mutants was tested first (PDIMR2-4, PDISR2 






expressing Pdi1p, with the exception of PDISR4 and PDISR5. These two mutants 
also exhibited less intense bands for PGK. This was a result of the two strains having 
impaired growth rates and so PDISR4 and PDISR5 were lysed at the lower cell 
concentration of OD600 0.138 ml-1 and OD600 0.129 ml-1 respectively rather than 
OD600 ~0.5ml-1 for all other strains. The PDISR4 and PDISR5 mutants also 
appeared to lack a second band between the band for yPdi1p and the band for PGK 
that was present in all of the other lysates (Fig 3.5.). The identity of this protein is 
unknown, but is likely the result of non-specific binding of either the PGK or yPdi1p 
antibodies to an unrelated protein or a truncated form of one of these proteins. The 
band for PGK appeared to migrate slower in PDISR4 and PDISR5 compared to the 
other PDIS/MRx mutants and the controls, however, this may have been the result 
of distortion of the gel when transferring. Purified yPdi1p migrated further than the 
)LJ:HVWHUQEORWIRUH[SUHVVLRQRI3GLSLQ¨pdi1 mutants  
Expression of Pdi1p in potential ¨pdi1mutants PDIMR2-4, PDISR2 and PDISR4-7 
using an anti-yeast Pdi1p antibody as well as a PGK antibody as a loading control. 
Pdi1p expressing strain 2736 and ¨pdi1 strain DN5 were used as controls as well as a 
Pdi1p positive cell extract and purified yeast Pdi1p. Bands for PDI and PGK are 
indicated on the right of the blot, with the unknown band indicated by a white arrow. 
The two strains not expressing PDI are indicated by black arrows 
58 
 
Pdi1p expressed in the yeast strains as it was isolated from E.coli cells and hence 
ZDVQRWJO\FRV\ODWHG'HVSLWHWKHSURPLVLQJUHVXOWRIKDYLQJJHQHUDWHGWZR¨SGL
mutants, neither could be revived from glycerol stocks held at -80oC and so new 
mutants were made through UV mutagenesis and screened for expression of Pdi1p 
(Fig 3.6.). 
The western blot for PDIMR17, 19 and PDIMR21-30 indicated that all of these 
strains still produced Pdi1p (Fig 3.6.). 
As all but two of the PDIS/MRx mutants remained expressers of PDI (Fig 3.5, Fig 
3.6) it is clear that the PDI1 gene is retained despite selecting against URA3 cells. 
This suggests that the plasmid is either being retained, or the plasmid version of 
PDI1 is integrating into the genome.  
3.1.4 Growth of putative mutants in YPD liquid medium 
The growth curves in YPD medium of strains PDIMR2-4, PDISR2 and PDISR4-7, 
were measured, as viability retained by supX in a ¨pdi1 strain would be expected to 
result in a growth defects and hence an observable change to the growth curve(4). 
Fig 3.6. Western blot for expreVVLRQRI3GLSLQ¨pdi1 mutants  
Expression of Pdi1p in potential ¨pdi1mutants PDIMR17, PDIMR19 and PDIMR21-30 
using an anti-yeast Pdi1p antibody as well as a PGK antibody as a loading control. 
Pdi1p expressing strain 2736 and ¨pdi1 strain DN5 were used as controls as well as a 
Pdi1p positive cell extract and purified yeast Pdi1p. The bands for PDI and PGK are 




























Fig 3.7. Growth of BY4741, 2736 and DN5 in YPD liquid medium  
Change in absorbance over time indicating growth in YPD liquid medium of 2736 (blue), 




   
The sporadic growth curve of PDISR2 is indicative of contamination (Fig 3.9), as 
many bacterial strains form aggregates, the presence of which would result in 
artificially high absorbance readings. All other mutants, however, had growth curves 
absent of this sporadic spiking, suggesting that only PDISR2 was affected by 
contamination (Fig 3.7. ± 3.9.). The PDIS/MRx mutants all had a longer lag phase 




























































)LJ*URZWKRIDQG89PXWDJHQHVLVJHQHUDWHGSRWHQWLDO¨pdi1 mutants in 
YPD liquid media 
Change in absorbance over time indicating growth in YPD liquid medium of 2736 (blue) 
as a control, and mutants PDIMR2 (orange), PDIMR3 (grey) and PDIMR4 (yellow). 
)LJ*URZWKRIDQGVSRQWDQHRXVO\JHQHUDWHGSRWHQWLDO¨pdi1 mutants in 
YPD liquid media 
Change in absorbance over time indicating growth in YPD liquid medium of 2736 (blue) 
as a control, and mutants PDISR2 (orange), PDISR4 (grey). PDISR5 (yellow), PDISR6 
(green) and PDISR7 (light blue). 
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phase varied considerably between mutants ranging from 14.5 hrs for PDISR7 to 
31.25 hours for PDIMR3. The maximum growth rate of the 2736 parent strain control 
was 0.179hrs-1 while the PDISMRx mutants exhibited maximum growth rates 
ranging between 0.2hrs-1, for PDISR7, and 0.095hrs-1 for PDISR6 (Fig 3.8., Fig 3.9.). 
For all of the PDISMRx mutants, with the exception of PDISR6 and PDIMR3, the 
maximum biomass exceeds that of 2736 (Fig 3.8., Fig 3.9.). 2736 parent strain 
control had a maximum absorbance at OD600 ~2.3, while all PDISRx mutants and 
all PDIMRx mutants reached maximum absorbances of OD600 ~2.8 and OD600 ~2.5 
respectively, with the obvious exceptions of PDISR6 and PDIMR3. This maximum 
absorbance for the PDIS/MRx mutants was at 62hrs, the final data point of the 
experiment, and hence the maximum biomass may have increased if the experiment 
was to continue for longer. 
An analysis of growth in liquid culture analysis was only performed on early various 
PDIS/MRx mutants. For PDIMR17, 19 and PDIMR21-M30 growth curve analysis 
was not performed, as once it was established that they remained producers of PDI 
no further time was invested in characterising these mutants. 
A consistent trend from all of the PDIS/MRx mutants is an increased lag phase 
compared with the 2736 parent strain control, this indicates that the mutation that 
provides resistance to 5-FOA is detrimental to the cells. There is, however, wide 
variation between PDIS/MRx mutants for both duration of lag phase and maximum 
growth rate, this indicates that the PDIS/MRx mutants do not have a conserved 
mutation between them that results in the 5-FOA resistance. 
3.1.5 Polymerase chain reaction of genomic DNA to amplify PDI1 gene and 
check for a recombination event 
In order to check for recombination of the plasmid PDI1 gene into the genome a 
PCR reaction was performed to amplify the genomic PDI1 of PDIS/MRx mutants. If 
fragments generated from the PCR reaction were the same size as those for a 2736 
parent strain control then it would suggest that the genomic disrupted pdi1:his3 gene 
present in this strain is unmodified. If there has been a recombination event the PDI1 
DNA fragment would be expected to be smaller as it is absent of the HIS3 disruption. 
Oligonucleotide primers, -983_pdi1_F, -972_pdi1_R, -500_pdi1_F and -
504_pdi1_R, complementary to ~1000bp and ~500bp up and down stream of the 
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PDI1 gene were designed and used with PCR in an attempt to amplify the PDI1 
gene region from the mutant strains. Initially genomic DNA was prepared from the 
2736 strain and the sample run on an agarose gel to confirm presence of genomic 
DNA. This  DNA was then used as a template for the PCR reaction at the 
FDOFXODWHGRSWLPXPFRQGLWLRQVIRUSULPHUVZLWKDPHOWLQJWHPSHUDWXUH7PRIÛ&
but was unsuccessful at amplifying the PDI1 region. The presence of different DNA 
fragment generated by the reagents using in this PCR reaction confirmed that the 
PCR reaction mix was operational. A gradient PCR was also performed with a range 
RIWHPSHUDWXUHVIURPÛ&WRÛ&WKLVDJDLQZDVXQVXFFHVVIXODWDPSOLI\LQJDQ\
DNA. 
The repeated failure of this PCR reaction at a range of different annealing 
temperatures suggests that the oligonucleotide primers used for amplification of 
PDI1 are lacking in specificity for the upstream and downstream regions of the PDI1 
gene region. 
3.2 The phenotypic impact upon expressing glutathione peroxidases 7 and 8 
in yeast 
S. cerevisiae is absent of ER resident peroxidases, therefore yeast strains were 
transformed with human proteins GPx7 and GPx8 in order to alleviate ROS stress. 
Both GPx7 and GPx8 couple the detoxification of H2O2 and it was therefore 
expected that expression of GPx7 and GPx8 in a yeast system would result in 
increased resistance to H2O2, through direct degradation of H2O2. It is predicted to 
also increase OPF of disulphide bonded proteins, through direct reoxidation of Pdi1p 
by GPx7 and GPx8, but also through alleviating Ero1p inactivation by H2O2 by 
detoxification of H2O2.  
3.2.1 Construction of plasmids carrying GPX7 and GPX8 genes  
In order to express GPx7 and GPx8 in yeast plasmids were designed and produced 
with LEU2 selectable marker, allowing for simultaneous plasmid expression of 
pVT100U-KT and GLuc plasmid.  
3.2.1.1 pBEVY-L vector carrying native GPX7 and GPX8  
As the initial vectors available containing human native GPx7 and GPx8 cDNA were 
E.coli vectors the gene had to be transferred to a yeast vector. To do this PCR was 
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performed on plasmids pKEHS780-hGPx7 and Human GPx8 cDNA clone with 
oligonucleotide primers (kpnI_GPx7_F and sacI_GPx7_R for GPx7 and 
kpnI_GPx8_F and sacI_GPx8_R for GPx WR LQFRUSRUDWHUHVWULFWLRQVLWHV¶NSQ,
DQG¶VDF,VXFFHVVRIWKH3&5ZDVFRQILUPHGXVLQJDgarose gel electrophoresis 
(Fig 3.10.).  
Restriction digests of the inserts and the target vector: pBEVY-L followed by a 
ligation to create the intended plasmids. Competent E.coli cells were used for 
cloning of the ligation product and following a plasmid DNA extraction insert positive 
vectors were identified through excision of insert (Fig 3.11., Fig 3.12.). The resulting 
plasmids with a pBEVY-L backbone (Fig 2.2.) and native GPX7 and GPX8 were 
named pUKC3400 and pUKC3401 respectively. 
 
 
Fig 3.10. Agarose gel of GPX7 and GPX8 PCR 
generated DNA products for pBEVY-L backbone.  
Native GPX7 (left) and Native GPX8 (right), the native 
GPX8 PCR generated DNA product (right) was ran 
alongside other PCR generated DNA products (GPx7 and 
GPx8 PCR products for ligation into p6431 vector) for 




Fig 3.11. Restriction digests of plasmid extracts from E.coli cells transformed with 
pUKC3400. 
14 digested plasmid extracts from E.coli run to identify insert positive vectors, the inserts 
and corresponding insert positive vectors indicated by red squares. 
 
Fig 3.12. Restriction digests of plasmid 
extracts from E.coli cells transformed 
with pUKC3401. 
Three digested plasmid extracts run to 
identify insert positive vectors, the insert 
and corresponding insert positive vectors 
indicated by red squares 
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3.2.1.2 Native GPX7 and GPX8 with a GFP fusion 
Green Fluorescent Protein (GFP) is a chemiluminescent protein derived from 
Aequorea victoria jellyfish(85), the recombinant tagging of proteins of interest with 
GFP allows proteins localisation to be measured through fluorescence microscopy.  
To identify intracellular localisation of GPx7 and GPx8 absent of yeast ER signal 
sequence or retention sequences fusion of GFP to GPx7 and GPx8 was attempted. 
For this the same initial vectors were used but with different oligonucleotide primers 
(BamHI_GPx7_F and XbaI_GPx7_R for GPX7 and BamHI_GPx8_F and 
XbaI_GPx8_R for GPX8 WR LQFRUSRUDWH ¶ %DP+, DQG ¶ ;ED, UHVWULFtion sites 
allowing recombination into a p6431 backbone (Fig 2.1). Successful PCR was 
confirmed (Fig 3.13.) and was purified by PCR purification prior to restriction 
digestion,   ligation and cloning in competent E.coli. Restriction digests of plasmid 
extracts showed that no vectors contained inserts (Fig 3.14.). 
 
  
Fig 3.13. Agarose gel of GPX7 
and GPX8 PCR generated DNA 
products for p6431. 
Native GPX7 (well 2) and GPX8 
(well 3) run on an agarose gel to 
confirm success of PCR prior to 
ligation into p6431 plasmid.  
Fig 3.14. Restriction digests of plasmid extracts 
from E.coli cells transformed with pUKC3402 
and pUKC3403. 
Three plasmid extracts for both pUKC3402 (wells 
2-4) and pUKC3403 (wells 5-7) plasmids restriction 
digested to identify successful integration of the 





A repeat of PCR and PCR purification was performed with 3 identical PCR reactions 
combined per gene amplified (Fig 3.15.), this was to ensure ample insert clones to 
maximise chances of ligation success. The PCR product was purified through gel 
extraction (Fig 3.16.).  
  
Fig 3.15. Native GPX7 and GPX8 PCR generated DNA 
products and purified PCR generated DNA products.  
Following the unsuccessful previous attempt PCR was 
repeated with three fold as much PCR generated DNA 
product (wells 2-4) and purified PCR generated DNA 
products (wells 5-7) of GPX7 (wells 2 and 5), GPX8 (wells 
3 and 6) and a PCR control of a reaction shown previously 
to work (GPX8 for pBEVY-L) (wells 4 and 7). 
Fig 3.16. Restriction digests of native GPx7, GPx8, 
p6431 and PCR control for gel extraction and 
purification. 
Using the restriction enzymes BamHI and XbaI GPX7 
(well 4), GPX8 (well 6), p6431 (well 8) and PCR 
control (GPx8 for pBEVY-L) (well 2) were restriction 




Multiple bands were seen in restriction digests of GPX7 and GPX8, the expected 
bands of 534bp and 630bp respectively were present, although as the 0.5kb band 
of the DNA ladder was not visible this was approximated. An additional band at ~4kb 
for GPx7 and ~3kb for GPx8 was also present, only the insert was excised from the 
gel for gel purification. 
Quantification of the concentration of DNA in the purified sample indicated there 
was very little DNA present, as well as significant contamination of the sample as 
indicated by the OD260/230 ratios, all of which considerably lower than the ideal ratio 
of 2.0-2.2. The ideal ratio for OD260/280 to indicate purity of DNA is 1.8, all of the 
samples, however, had ratios higher than this, typically a value lower than the ideal 
ratio is indicative of contamination (Fig 3.17.).  
 
  Absorbance at different wavelengths 
Gel Purified 
product 
OD260 OD280 OD230 OD260/280 OD260/230 Concentration 
(ng/µl) 
GPx7 0.329 0.166 0.967 1.98 0.34 16.4 
GPx8 0.246 0.088 0.301 2.79 1.09 12.3 




3.2.1.3 pTH644 vector carrying GPX7 and GPX8 chimeric constructs 
As human native GPx7 and GPx8 is absent of ER localisation signals it may not 
have been localising to the ER. Therefore chimeric gene constructs of GPX7 and 
GPX8 were made by von der Haar, T. (school of biosciences) by Gibson assembly 
with a pTH644-L plasmid backbone (Fig 2.3.). The first set of constructs were GPx7 
and GPx8 with HA tags and a substitution of the KREDL and KDEL ER retention 
sequences of GPx7 and GPx8 respectively for a yeast HDEL ER retention 
sequence. These gene constructs with HDEL ER retention sequence in a pTH644-
Fig 3.17. Absorbance of gel purified inserts GPX7 and GPX8 and linearised p6431 
at OD260, OD280 and OD230  
The absorbance of GPX7, GPX8 and p6431 measured using a nanodrop 
spectrophotometer with the ratios of OD260/280 and OD260/230 along with the final DNA 
concentration to determine levels of purity of purified DNA.  
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L backbone (Fig 2.3.) were named pUKC3404 and pUKC3405 for GPx7 and GPx8 
respectively. The second set of constructs had, HDEL yeast ER retention sequence, 
HA tag and an N-terminal Ost1 pre-sequence and MAT pro-sequence yeast ER 
signal sequence. These gene constructs with both HDEL ER retention sequence 
and yeast ER signal sequences in pTH644 were named pUKC3406 and pUKC3407 
for GPx7 and GPx8 respectively. 
3.2.1.3.1 GPX7 and GPX8 with native ER signal sequence but yeast ER 
retention sequence 
In order to isolate the pUKC3404, pUKC3405, pUKC3406 and pUKC3407 plasmids 
for transformation into yeast they were extracted from transformed Top10 E.coli 
colonies present on LB + Ampicillin selective medium.  This extraction was 
performed in duplicate, with the exception of pUKC3407 due to one of the replicates 
lacking viability during overnight growth. Agarose gel electrophoresis of a sample of 
double restriction digested plasmid extract confirmed integration of insert into the 
vector for all plasmids as two bands were seen in each of the samples, with the 
exception of the first duplicate of pUKC3404 which was not used. The expected 
sizes of DNA fragments of GPX7 and GPX8 with HDEL yeast ER retention 
Fig 3.18. Restriction digests of plasmid extracts 
from E.coli cells transformed with pUKC3404, 
pUKC3405, pUKC3406 and pUKC3407. 
Restriction digests using restriction enzymes BamHI 
and HindIII, the presence of correctly sized inserts 
were seen for all pUKC340x plasmids, with the 
exception of the first replicate for pUKC3404, with 




sequence were 596bp and 662bp respectively, while the expected sizes of GPX7 
and GPX8 with both ER retention sequence and ER signal sequence were 686bp 
and 725bp respectively. Use of the DNA ladder shows these inserts to be of correct 
size (Fig 3.18.).  
In parallel to extraction of GPx7 and GPx8 constructs from pTH644-L plasmid the 
identical constructs were also cloned into pTH644-U, again constructed by von der 
Haar, T. (School of Biosciences, University of Kent), these plasmids were extracted 
from competent E.coli and inclusion of insert confirmed but were otherwise unused 
in this study. 
3.2.2 Expression and cellular retention of glutathione peroxidases 7 and 8 
Plasmids containing GPX7 and GPX8 genes were transformed into yeast and so 
the successful expression of these recombinant proteins had to be confirmed.  
3.2.2.1 Native GPX7 and GPX8  
3.2.2.1.1 Confirming expression of glutathione peroxidases 7 and 8  
Initially BY4741, 2736 and DN5 were all transformed with pUKC3400 and the 
expression of His-Tagged native GPX7 protein tested for via western blot with a 
monoclonal anti 6xHis tag antibody, however, this showed that only 2736 and DN5 
were successfully expressing GPx7 (Fig 3.19.). Alongside all western blots of His 
tagged GPx7 and GPx8 a control of purified His tagged GPx7 and GPx8, a gift from 
Beal, D. M. (School of Biosciences, University of Kent), was run. Initially 10µL of a 
1/250 and a 1/500 dilution were used (Fig 3.19.) but was reduced to 5µL of a 1/500 





As a Pdi1p positive strain was required 2736 was chosen as the primary strain for 
initial investigations used for expression of GPx7 and GPx8. pUKC3401 was then 
transformed into 2736 once the plasmid had been constructed (Fig 3.20.). 
 
Fig 3.19. Western blot for the expression of native GPx7 
in 2736, BY4741 and DN5 strains transformed with 
pUKC3400 
A western blot to test for expression of His-tagged native 
GPx7 in 2736, DN5 and BY4741 strains transformed with 
pUKC3400 plasmid. 10µL of purified GPx7 at a 1/250 and 
1/500 dilution was run alongside the lysates. Bands 
indicating expression of GPx7 were seen for 2736 and DN5 
transformed with pUKC3400, but not for BY4741. 
Fig 3.20. Western blot for the 
expression of native GPx7 and GPx8 in 
2736 transformed with pUKC3400 and 
pUKC3401 
2736 strain was transformed with plasmids 
pUKC3401 and retransformed with 
pUKC3401. The expression of GPx7 and 
GPx8 was confirmed via comparison to 





Following preliminary investigations BY4741 and DN5 were later transformed, and 
2736 retransformed, with the pUKC3400 and pUKC3401 plasmids. In the case of 
BY4741 both GPx7 and GPx8 were being expressed (Fig 3.21.), where as in DN5 
it appears that either only GPx7 was being expressed (Fig 3.22.), or that GPx8 was 
at too low concentration to be seen. This is supported by the expression of GPx8 in 
both BY4741 and 2736 generated a weak signal (Fig 3.21.) and that DN5 is less 












Fig 3.21. Western blot for the expression of native GPx7 and GPx8 
in BY4741 and 2736 transformed with pUKC3400, pUKC3401 
A western blot for expression of native GPx7 and GPx8 in strains 
BY4741 and 2736 resulting from a transformation with pUKC3400 and 
pUKC3401. Bands, albeit faint, were seen for both GPx7 and GPx8 in 
BY4741 and 2736. 
Fig 3.22. Western blot for the expression of native GPx7 and 
GPx8 in DN5 transformed with pUKC3400, pUKC3401 
A western blot for expression of native GPx7 and GPx8 in DN5 
transformed with pUKC3400 and pUKC3401. A faint band was 
seen for GPx7, but not for GPx8.  An additional control of 
previously made 2736 lysates which were known to have shown 





3.2.2.1.2 Cellular retention of native glutathione peroxidases 7 and 8 
As the native GPx7 and GPx8 proteins were absent of yeast ER retention or signal 
sequences a western blot of protein precipitates from the medium was performed to 
investigate whether the majority of the GPx7 and GPx8 was being retained 
intracellularly or secreted. The blot, however, had too much background noise and 
neither control bands nor bands that would indicate secretion of GPx7 and GPx8 
could not be seen as a result of this. Due to time constraints the blot was not able 
to be repeated. 
3.2.2.2 BY4741 expressing glutathione peroxidases 7 and 8 constructs 
3.2.2.2.1 Confirming expression of glutathione peroxidases 7 and 8 constructs 
The expression of modified GPx7 and GPx8 proteins in transformed BY4741 was 
confirmed by performing a western blot using a monoclonal HA-probe antibody. The 
lysates of BY4741 transformed with pUKC3404, pUKC3405, pUKC3406 and 
pUKC3407 indicate that GPx7 and GPx8 with yeast ER retention sequence as well 
as with both yeast ER retention sequence and yeast ER signal sequence are being 
expressed (Fig 3.23.). The band for GPx7 with yeast ER retention sequence is very 
faint but can be seen at ~25kDa while the band for GPx8 with ER retention sequence 
is in between ~25kDa and ~35kDa (Fig 3.23.). The expression of GPx7 and GPx8 
with both yeast ER retention sequence and ER signal sequence was confirmed by 
Fig 3.23. Western blot of BY4741 transformed with pUKC3404, pUKC3405, 
pUKC3406 and pUKC3407 lysates and protein precipitation from medium.   
Lysates and protein precipitates of medium from overnight growth were ran in 
parallel for BY4741 transformed with pUKC3404, pUKC3405, pUKC3406 and 




bands at ~35kDa for both GPx7 and GPx8, but with GPx8 having migrated slightly 
less (Fig 3.23.). 
The theoretical molecular weights of each protein are 22kDa GPx7 and 25kDa for 
GPx8 with HDEL ER retention sequence, while GPx7 and GPx8 constructs with 
HDEL ER retention sequence and ER signal sequence is ~25kDa and ~28kDa 
respectively. Theorised molecular weights calculated using ExPASy Bioinformatics 
Resource Portal compute pI/Mw online resource (web.expasy.org/compute_pi/).  
3.2.2.2.2 Cellular retention of glutathione peroxidases 7 and 8 constructs 
To show whether presence of ER retention sequence and ER signal sequence was 
leading to successful intracellular retention protein precipitates from medium of 
BY4741 transformed with pUKC3404, pUCK3405, pUKC3406 and pUKC3407 after 
overnight (~16-18 hr) growth were ran alongside lysates. This indicated that the all 
of GPx7 and GPx8 constructs are being cellularly retained as no bands can be seen 
that would indicate secretion into the medium (Fig 3.23.).  If secretion of these ER 
targeted proteins was occurring a dominant band would be expected as a result of 





Fig3.24. Western blot of DN5 transformed with pUKC3404, pUKC3405, 
pUKC3406 and pUKC3407 lysates and protein precipitation from medium.   
Lysates and protein precipitates of medium from overnight growth were ran in 
parallel for DN5 transformed with pUKC3404, pUKC3405, pUKC3406 and 




3.2.2.3 $¨pdi1 strain expressing glutathione peroxidases 7 and 8 constructs 
3.2.2.3.1 Confirming expression of glutathione peroxidases 7 and 8 constructs 
7RLGHQWLI\ZKHWKHU*3[DQG*3[FRQVWUXFWVZHUHEHLQJH[SUHVVHGLQWKH¨pdi1 
strain DN5 transformed with pUKC3404, pUKC3405, pUKC3406 and pUKC3407 a 
western blot was performed with a monoclonal HA-probe antibody. Bands can be 
seen for the GPx7 and GPx8 constructs expressed in DN5, with the exception of 
GPx7 with ER retention sequence only (Fig 3.24.). 
When this plasmid was transformed into BY4741 and expression of GPx7 tested for 
the band was very faint (Fig 3.23.) and hence there may be expression but at too 
low levels to detect due to excess background noise from the blot. There appears 
to be two bands present for GPx7 with both yeast ER signal sequence and retention 
sequence, one at ~35kda, which was expected from the bands seen previously (Fig 
3.23.), but an additional band just above the 25kda marker of the protein ladder was 
also seen.  
3.2.2.3.2 Western Blot to assay for cellular retention of protein 
To check for intracellular retention of GPx7 and GPx8 with ER retention sequence 
and ER signal sequences protein precipitates from medium of O/N (~16-18hrs) 
cultures for DN5 transformed with pUKC3404, pUKC3405, pUKC3406 and 
pUKC3407 shows absence in bands for suggests that there is not significant 
secretion of the protein and hence is retained intracellularly (Fig 3.23.).  
3.2.3 Changes to sensitivity to hydrogen peroxide as a result of expressing 
glutathione peroxidases 7 and 8  
Expression of GPx7 reportedly leads to reduced sensitivity to H2O2 in human 
tissue(86). Therefore to investigate as to whether GPx7 and GPx8 confers increased 
resistance to H2O2 in a yeast system through intracellular H2O2 processing cells 
were exposed to a range of concentrations of H2O2. H2O2 is a redox reagent and 
causes damage to protein, lipids and nucleic acids(87), therefore it would be expected 
that cells more able to detoxify H2O2 would have increased growth rates. To test this 
hypothesis both growth analysis in liquid culture and sensitivity assays on solid 




3.2.3.1 Growth in YNB-Leu liquid medium in presence of hydrogen peroxide 
To investigate whether GPx7 and GPx8 mediate a resistance to H2O2 growth curves 
in 0mM-4mM H2O2 were performed.  
3.2.3.1.1 BY4741 and 2736 expressing native glutathione peroxidases 7 and 8 
BY4741 and 2736 each transformed with pBEVY-L empty vector control (Fig2.2.), 
pUKC3400 and pUKC3401 were grown in liquid YNB-Leu minimal medium to 





















































2736 pBEVY-L 2736 pUKC3400
2736 pUKC3401
Fig 3.25. Growth of BY4741 and 2736 expressing native GPx7 and GPx8 in liquid 
medium in 0mM H2O2 
Change in absorbance over time indicating growth in YNB-Leu liquid medium of BY4741 
(left) and 2736 (right) expressing native GPx7 (orange) and GPx8 (grey), with each 
respective strain transformed with pBEVY-L empty vector as a control (blue) in the 


















Fig 3.26. Growth of BY4741 and 2736 expressing native GPx7 and GPx8 in liquid 
medium in 1mM H2O2 
Change in absorbance over time indicating growth in YNB-Leu liquid medium of 
BY4741 (left) and 2736 (right) expressing native GPx7 (orange) and GPx8 (grey), with 













































































































2736 pBEVY-L 2736 pUKC3400
2736 pUKC3401
Fig 3.27. Growth of BY4741 and 2736 expressing native GPx7 and GPx8 in liquid 
medium in 2mM H2O2 
Change in absorbance over time indicating growth in YNB-Leu liquid medium of BY4741 
(left) and 2736 (right) expressing native GPx7 (orange) and GPx8 (grey), with each 












































































BY4741 pBEVY-L BY4741 pUKC3400
BY4741 pUKC3401
Fig 3.28. Growth of BY4741 and 2736 expressing native GPx7 and GPx8 in liquid 
medium in 3mM H2O2 
Change in absorbance over time indicating growth in YNB-Leu liquid medium of BY4741 
(left) and 2736 (right) expressing native GPx7 (orange) and GPx8 (grey), with each 
























































2736 pBEVY-L 2736 pUKC3400
2736 pUKC3401
Fig 3.29. Growth of BY4741 and 2736 expressing native GPx7 and GPx8 in liquid 
medium in 4mM H2O2 
Change in absorbance over time indicating growth in YNB-Leu liquid medium of BY4741 
(left) and 2736 (right) expressing native GPx7 (orange) and GPx8 (grey), with each 





  Fig 3.30. Maximum growth rate during log phase of BY4741 expressing native 
GPx7 and GPx8 in liquid medium at a range of H2O2 concentrations. 
A bar chart of the maximum growth rates calculated from growth curves of BY4741 in 
YNB-Leu liquid medium expressing native GPx7 and GPx8 in H2O2 concentrations 
ranging from 0mM to 4mM. Experiment performed in triplicate with standard error 
bars. 
 


































































































































































































































































Strain and Concentration of H2O2
Fig 3.31. Duration of lag phase of BY4741 expressing native GPx7 and GPx8 in 
liquid medium at a range of H2O2 concentrations. 
A bar chart of the duration of lag phase calculated from growth curves of BY4741 in 
YNB-Leu liquid medium expressing native GPx7 and GPx8 in H2O2 concentrations 
ranging from 0mM to 4mM. 
 









































































































































































































































Fig 3.32. Maximum growth rate during log phase of 2736 expressing native GPx7 
and GPx8 in liquid medium at a range of H2O2 concentrations. 
A bar chart of the maximum growth rates calculated from growth curves of 2736 in 
YNB-Leu liquid medium expressing native GPx7 and GPx8 in H2O2 concentrations 
ranging from 0mM to 4mM. 
 
Fig 3.33. Duration of lag phase of 2736 expressing native GPx7 and GPx8 in 
liquid medium at a range of H2O2 concentrations. 
A bar chart of the duration of lag phase calculated from growth curves of 2736 in YNB-
Leu liquid medium expressing native GPx7 and GPx8 in H2O2 concentrations ranging 
from 0mM to 4mM. 
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Growth curves for BY4741 and 2736 show no significant changes as a result of 
expressing GPx7 or GPx8, particularly at low concentrations of H2O2 (Fig 3.24. ± 
Fig 3.26.). Only once a concentration of 3mM H2O2 is reached is there some 
deviation between the growth curves of the control and strains expressing GPx7 or 
GPx8 (Fig 3.27.). In 2736 this discrepancy is more obvious as 2736 expressing 
GPx8 reaches stationary phase with an absorbance of OD600 ~4.0 in both 3mM and 
4mM H2O2 (Fig 3.27., Fig 3.28.), this is higher than the 2736 control which reached 
stationary phase at an OD600 ~3.3 in 3mM H2O2 and ~3.5 in 4mM. 2736 expressing 
GPx7 also reaches stationary phase at an absorbance higher than that of the control 
with an OD600 of 3.5 in 3mM H2O2 and 3.6 in 4mM H2O2 (Fig 3.27., Fig 3.28.). 
BY4741, however, in contrast to 2736, reaches stationary phase at a lower 
absorbance than the control when expressing GPx8 with an OD600 of ~3.3 at 3mM 
and ~3.5 at 4mM, compared with the control reaching stationary phase at OD600 
~3.5 and ~3.6 at 3mM and 4mM respectively (Fig 3.27., Fig 3.28.). BY4741 
expressing GPx7 at 3mM reaches stationary phase at an absorbance very similar 
to that of the control, however, at 4mM stationary phase is only reached at OD600 
~3.3 (Fig 3.27., Fig 3.28.). 
The most obviously affected strain from high concentrations of H2O2 was BY4741 
expressing GPx8 at 4mM concentration (Fig 3.27.), however, this strain showed a 
large error bars and hence this result has low reliability (Fig 3.29., Fig 3.30.).  
A chart of the maximum rates achieved during log phase growth and duration of lag 
phase shows that there are no statistically significant changes in maximum rate or 
duration of lag phase as a result of expressing GPx7 and GPx8, as P values of an 
unpaired two-tailed t-test were greater than the significant interval of 0.05. This was 
the case for any concentration of H2O2 for either BY4741 or 2736 as a result of 
expression of native GPx7 or GPx8 (Fig 3.29., Fig 3.31.), with the exception of 2736 
in 0mM where there is a statistically significant increase in duration of lag phase, 
with an unpaired two-tailed t-test P value of 0.0177, lower than the significance 
interval of 0.05. The duration of lag phase increases in all strains as a result of 
increasing concentration of H2O2. 
Therefore expression of native human GPx7 and GPx8 results in no statistically 
significant change in growth rates in PDI expressing strains BY4741 and 2736. 
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3.2.3.1.2 BY4741 expressing glutathione peroxidases 7 and 8 constructs 
As there was no effect on growth rates from native human GPx7 and GPx8 the 
constructs of these genes with ER localisation signals were expressed in a PDI 
expressing strain. This was to investigate whether the resistance to H2O2 was a 
result of GPx7 and GPx8 not being localised to the ER. The change in sensitivity to 
H2O2 in liquid YNB-Leu medium of BY4741 transformed with pUKC3404, 
pUKC3405, pUKC3406 and pUKC3407 to H2O2 as a result of expressing GPx7 and 
GPx8 with ER localisation sequences was investigated. This was to check if the lack 
of statistically significant changes in H2O2 sensitivity for BY4741 and 2736 
transformed with pUKC3400 and pUKC3401 were a result of the native GPx7 and 
GPx8 proteins not being resident in the ER. 
  
Fig 3.34. Growth of BY4741 expressing GPx7 and GPx8 constructs in liquid 
medium in 0mM H2O2 
Change in absorbance over time indicating growth in YNB-Leu liquid medium of 
BY4741 expressing GPx7 and GPx8 with either an ER retention sequence only 
(orange and grey respectively), or both an ER retention sequence and ER signal 























BY4741 pBEVY-L BY4741 pUKC3404 BY4741 pUKC3405





























BY4741 pBEVY-L BY4741 pUKC3404 BY4741 pUKC3405

























BY4741 pBEVY-L BY4741 pUKC3404 BY4741 pUKC3405
BY4741 pUKC3406 BY4741 pUKC3407
Fig 3.35. Growth of BY4741 expressing GPx7 and GPx8 constructs in liquid 
medium in 1mM H2O2 
Change in absorbance over time indicating growth in YNB-Leu liquid medium of 
BY4741 expressing GPx7 and GPx8 with either an ER retention sequence only 
(orange and grey respectively), or both an ER retention sequence and ER signal 
sequence (yellow and dark blue respectively) in 1mM H2O2. 
 
Fig 3.36. Growth of BY4741 expressing GPx7 and GPx8 constructs in liquid 
medium in 2mM H2O2 
Change in absorbance over time indicating growth in YNB-Leu liquid medium of BY4741 
expressing GPx7 and GPx8 with either an ER retention sequence only (orange and grey 
respectively), or both an ER retention sequence and ER signal sequence (yellow and 











Fig 3.38. Growth of BY4741 expressing GPx7 and GPx8 constructs in liquid 
medium in 4mM H2O2 
Change in absorbance over time indicating growth in YNB-Leu liquid medium of BY4741 
expressing GPx7 and GPx8 with either an ER retention sequence only (orange and grey 
respectively), or both an ER retention sequence and ER signal sequence (yellow and 


























BY4741 pBEVY-L BY4741 pUKC3404 BY4741 pUKC3405
BY4741 pUKC3406 BY4741 pUKC3407
Fig 3.37. Growth of BY4741 expressing GPx7 and GPx8 constructs in liquid 
medium in 3mM H2O2 
Change in absorbance over time indicating growth in YNB-Leu liquid medium of 
BY4741 expressing GPx7 and GPx8 with either an ER retention sequence only 
(orange and grey respectively), or both an ER retention sequence and ER signal 

























BY4741 pBEVY-L BY4741 pUKC3404 BY4741 pUKC3405









Fig 3.38. Maximum growth rate during log phase of BY4741 expressing GPx7 and 
GPx8 constructs in liquid medium at a range of H2O2 concentrations. 
A bar chart of the maximum growth rates calculated from growth curves of BY4741 in 
YNB-Leu liquid medium expressing GPx7 and GPx8 constructs in H2O2 concentrations 






















































































































































































































































































































































































Strain and concentration of H2O2
Fig 3.40. Duration of lag phase of BY4741 expressing native GPx7 and GPx8 in 
liquid medium at a range of H2O2 concentrations. 
A bar chart of the duration of lag phase calculated from growth curves of BY4741 in 
YNB-Leu liquid medium expressing GPx7 and GPx8 constructs in H2O2 concentrations 





































































































































































































































































































































































































































At all concentrations of H2O2 the duration of lag phase of BY4741 strain expressing 
the GPx7 and GPx8 constructs was very similar to that of the pBEVY-L empty vector 
control strain (Fig 3.40.). Across all concentrations pUKC3404 appeared to have a 
shorter lag phase than the control, however, this phenotype became more apparent 
at higher concentrations (Fig 3.40.) this finding, however, was not statistically 
significant, as the unpaired two-tailed t-test P values for BY4741 pUKC3404 at a 
range of concentrations when compared to the control were all greater than the 
significance interval of 0.05. The maximum growth rates also indicated no 
statistically significant changes as a result of expressing the GPx7 and GPx8 
constructs, as again there were no two-tailed t-test P values less than the 
significance interval of 0.05, however, there was a general trend of all strains 
towards lower growth rate at higher concentration of H2O2 (Fig 3.39.). 
One trend that was seen was that the different transformants reached stationary 
phase at different absorbances to each other. Consistent across all of the H2O2 
concentrations BY4741 transformed with pUKC3407 reached stationary phase at 
the highest absorbance, while BY4741 transformed with pUKC3405 was the lowest. 
The second lowest was the BY4741 pBEVY-L control followed by pUKC3404 and 
pUKC3406 which reached stationary phase at similar absorbances (Fig 3.34. ± Fig 
3.38.). Likewise, it is the two strains that reached stationary phase with the lowest 
aborbances: BY4741 transformed with pUKC3405 and pBEVY-L that also enter 
decline phase earlier than the other strains (Fig 3.34. ± Fig 3.38.). This indicates 
that these two strains may be more susceptible to growth inhibitions at lower nutrient 
availability and that BY4741 expressing GPx8 with both an ER retention sequence 
and an ER signal sequence is more resistant.  
Nevertheless expressing GPx7 and GPx8 with ER localisation signals does not 
appear to have any effect on the sensitivity of BY4741 to H2O2. 
3.2.3.1.3 $¨ pdi1 strain expressing glutathione peroxidases 7 and 8 constructs 
As the primary substrate for the GPx7 and GPx8 coupled detoxification of H2O2 is 
Pdi1p it was originally proposed that expression in a strain that expresses Pdi1p, 
such as BY4741 or 2736, would mediate in vivo H2O2 detoxification, while a ¨pdi1 
strain, such as DN5, would not. This would not result in an increased resistance to 
H2O2 that could be shown through growth curve analysis in liquid culture. However, 
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in light of the finding that GPx7 and GPx8 with ER localisation signals did not incur 




























DN5 pBEVY-L DN5 pUKC3404 DN5 pUKC3405 DN5 pUKC3406 DN5 pUKC3407
Fig 3.42. Growth of DN5 expressing GPx7 and GPx8 constructs in liquid medium 
in 1mM H2O2 
Change in absorbance over time indicating growth in YNB-Leu liquid medium of DN5 
expressing GPx7 and GPx8 with either an ER retention sequence only (orange and 
grey respectively), or both an ER retention sequence and ER signal sequence (yellow 
and dark blue respectively) in 1mM H2O2. 
Fig 3.41. Growth of DN5 expressing GPx7 and GPx8 constructs in liquid medium 
in 0mM H2O2 
Change in absorbance over time indicating growth in YNB-Leu liquid medium of DN5 
expressing GPx7 and GPx8 with either an ER retention sequence only (orange and 
grey respectively), or both an ER retention sequence and ER signal sequence (yellow 

























































DN5 pBEVY-L DN5 pUKC3404 DN5 pUKC3405 DN5 pUKC3406 DN5 pUKC3407
Fig 3.43. Growth of DN5 expressing GPx7 and GPx8 constructs in liquid medium 
in 2mM H2O2 
Change in absorbance over time indicating growth in YNB-Leu liquid medium of DN5 
expressing GPx7 and GPx8 with either an ER retention sequence only (orange and 
grey respectively), or both an ER retention sequence and ER signal sequence (yellow 
and dark blue respectively) in 2mM H2O2. 
Fig 3.44. Growth of DN5 expressing GPx7 and GPx8 constructs in liquid medium 
in 3mM H2O2 
Change in absorbance over time indicating growth in YNB-Leu liquid medium of DN5 
expressing GPx7 and GPx8 with either an ER retention sequence only (orange and 
grey respectively), or both an ER retention sequence and ER signal sequence (yellow 




















































DN5 pBEVY-L DN5 pUKC3404 DN5 pUKC3405 DN5 pUKC3406 DN5 pUKC3407
Fig 3.45. Growth of DN5 expressing GPx7 and GPx8 constructs in liquid medium 
in 4mM H2O2 
Change in absorbance over time indicating growth in YNB-Leu liquid medium of DN5 
expressing GPx7 and GPx8 with either an ER retention sequence only (orange and 
grey respectively), or both an ER retention sequence and ER signal sequence (yellow 
and dark blue respectively) in 4mM H2O2. 
 
Fig 3.46. Maximum growth rate during log phase of DN5 expressing GPx7 and 
GPx8 constructs in liquid medium at a range of H2O2 concentrations. 
A bar chart of the maximum growth rates calculated from growth curves of DN5 in 
YNB-Leu liquid medium expressing GPx7 and GPx8 constructs in H2O2 concentrations 



















































































































































































































































































































































Strains and concentration of H2O2
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DN5 transformed with pUKC3404, pUKC3405, pUKC3406 and pUKC3407 all had 
growth curves very similar to each other (Fig 3.41. ± Fig 3.45.) with minor variation 
between maximum growth rate during log phase (Fig 3.46.) and duration of lag 
phase (Fig 3.47.). The growth curves of the DN5 pBEVY-L empty vector control 
showed significant spiking at 0mM to 2mM H2O2 (Fig 3.41. ± Fig 3.43.) When the 
individual repeats for 0mM to 2mM DN5 pBEVY-L control were examined there 
was a large degree of variability between repeats and hence resulting in the 
peculiar growth curves. The same trend was seen as with BY4741 where DN5 
expressing the GPx7 and GPx8 constructs reached stationary phase at a higher 
OD600 than that of the control across all concentrations of H2O2 (Fig 3.41. ± Fig 
3.45.), again suggesting that there may be lessened inhibition to growth at lower 
nutrient availability as a result of expressing GPx7 and GPx8 constructs. 
Nevertheless there is no notable increased resistance to H2O2 LQWKH¨pdi1 strain 




Fig 3.47. Duration of lag phase of DN5 expressing native GPx7 and GPx8 in 
liquid medium at a range of H2O2 concentrations. 
A bar chart of the duration of lag phase calculated from growth curves of BY4741 in 
YNB-Leu liquid medium expressing GPx7 and GPx8 constructs in H2O2 concentrations 
ranging from 0mM to 4mM with standard error bars. 
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3.2.3.2 Growth on solid YNB-Leu medium with a range of hydrogen peroxide 
concentrations 
To augment the data provided by the growth curves a sensitivity assay on was 
performed on solid YNB in 0mM to 4mM H2O2 to provide qualitative data regarding 
a possible change in resistance to H2O2 as a result of expressing GPx7 and GPx8.  
3.2.3.2.1 2736 expressing native glutathione peroxidases 7 and 8 
As this was a preliminary assay 2736 was used over BY4741, 2736 transformed 
with pUKC3400, pUKC3401 and pBEVY-L empty vector and hence expressing 
GPx7 and GPx8 without ER localisation sequences. The cultures serial dilutions 
from OD600 0.1 to OD600 1x10-4 were added to YNB-Leu solid medium with H2O2 
concentrations ranging from 0mM to 4mM increasing in increments of 1mM (Fig 
3.48.) to remain consistent with the concentrations used for assaying growth in liquid 
medium. Due to the temperature sensitivity nature of the H2O2 a 24 hour incubation 
period was used, as all 2736 strain yeast transformants in liquid culture at all 
concentrations of H2O2, with the exception of 4mM H2O2, had entered stationary 
phase growth within 24 hours, it was expected that some growth would be exhibited 
at all concentrations of H2O2 on solid medium.  
There are no distinct changes in levels of growth between the control 2736 pBEVY-
L strain and strains expressing GPx7 or GPx8 at both 0mM and 1mM H2O2 
concentrations (Fig 3.48.). Despite a range of 0mM to 4mM H2O2 only data for 0mM 
and 1mM was included, as at 1mM H2O2 all strains exhibit dramatic growth inhibition 
(Fig 3.48.) and at 2mM, 3mM and 4mM no signs of growth were seen at all. This 
suggests greater inhibition of growth as a result of solid medium rather than liquid 
medium than was initially predicted. Therefore native human GPx7 and GPx8 do 









3.2.3.2.2 BY4741 expressing glutathione peroxidases 7 and 8 constructs 
Due to low growth on 1mM H2O2 and non-existent growth on 2mM H2O2 for BY4741 
mutants transformed with pUKC3400 and pUKC3401 (Fig 3.48.) the range of H2O2 
concentrations was changed to 0mM to 2mM with 0.5mM intervals (Fig 3.49.). It was 
expected that subtle differences in sensitivity would become apparent with the 
smaller intervals 
Fig 3.48. Growth of 2736 expressing native GPx7 and GPx8 
at varying cell densities on solid YNB-Ura medium in 0mM 
and 1mM H2O2 
2736 strain yeast transformed with pBEVY-L control, pUKC3400 
and pUKC3401 plated onto YNB-Leu Agar by replica plating in 4 
1/10 serial dilutions from OD600 10-1 to OD600 10-4 in biological 
triplicate and technical duplicate with H2O2 concentrations 
ranging from 0mM to 4mM in 1mM intervals. Data from 2mM-







At the highest H2O2 concentration of 2mM there was some inhibition of growth (Fig 
3.49.) but not to the same extent as seen previously (Fig 3.48.). As such the 
differences in growth as a result of the 0.5mM intervals were small and the 
transformants were not tested at a concentration of H2O2 that was completely 
inhibitory to growth. Nonetheless, no obvious changes in resistance to H2O2 as a 
result of expressing GPx7 and GPx8 can be seen as a result of this assay (Fig 
3.49.).  
Fig 3.49. Growth of BY4741 expressing GPx7 and GPx8 constructs at 
varying cell densities on solid YNB-Ura medium in 0mM to 2mM H2O2 
BY4741 strain yeast transformed with pBEVY-L control, pUKC3404, 
pUKC3405, pUKC3406 and pUKC3407 plated onto YNB-Leu Agar by 
replica plating in 4 1/10 serial dilutions from OD600 10-2 to OD600 10-5 in 
biological triplicate with H2O2 concentrations ranging from 0mM to 2mM in 
0.5mM intervals.  
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3.2.4 Changes in levels of intracellular hydrogen peroxide as a result of 
expressing glutathione peroxidases 7 and 8 
A more direct approach to measure the intracellular levels of H2O2, and hence 
determine the H2O2 detoxification effects of GPx7 and GPx8, was to use flow 
cytometry. To determine intracellular levels of H2O2 H2DCFDA was used, this is an 
intracellular molecular probe for ROS, the acetate group on the dye is cleaved by 
intracellular esterases which primes the dye and increases cellular retention, before 
EHFRPLQJ WKH IOXRUHVFHQWPROHFXOH ¶¶ GLFKORURIOXRUHVFHLQ WKURXJK R[LGDWLRQ E\
ROS such as H2O2(88). As H2DCFDA is fluorescein derived the oxidised form has 
approximately the same excitation (492nm-495nm) and emission (517nm-527nm) 
spectra as fluorescein. This dye was used with flow cytometry to indicate the 
increase in percentages of fluorescent cells and hence efficiency of processing of 
intracellular ROS 
3.2.4.1 Intracellular hydrogen peroxide in BY4741, 2736 and DN5 expressing 
native glutathione peroxidases 7 and 8 
The increase in the percentage fluorescent cells as a result of addition of H2DCFDA 
from basal levels measured in absence of the dye gave an indication of levels of 
intracellular ROS. Hence by comparing strains expressing GPx7 and GPx8 to the 
pBEVY-L control suggested the levels of H2O2 processing by these proteins. 2mM 
H2O2 stress was also induced to mimic the ROS conditions that would result from 
over expression of a disulphide bonded protein and to investigate whether GPx7 or 
GPx8 has effects on reducing these levels.  
The first FACS analysis performed on 2736 transformed with pBEVY-L, pUKC3400 
and pUKC3401 showed promising results as addition of H2DCFDA dye to the control 
sample led to an increase in the percentage of fluorescent cells to 29.2% and then 
with the addition of 2mM H2O2 to the sample resulted in an even greater increase to 
33.9% (Fig 3.50.). As a result of expressing GPx7 there was an increase to 14.8% 
in absence of H2O2 and 19.4% in presence of H2O2, having a two-tailed t-test P 
value of 0.0048 and 0.034 respectively, this was lower than the significance interval 
of 0.05 and hence a statistically significant decrease in the percentage of fluorescent 
cells by 14.4% and 14.5%. Due to the level of decrease resulting from expression 
of GPx7 being approximately the same in both presence and absence of H2O2 it 
suggests that GPx7 is operating at its maximum rate in vivo resulting in maximum 
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decrease in the percentage of fluorescent cells of ~14.5% over the 4 hour incubation 
time of the experiment.  
 
 
GPx8 only had a mean increase in the percentage of fluorescent cells to 21.4% in 
absence of H2O2, with an unpaired two-tailed t-test P value of 0.31, and 20.6% in 
presence of H2O2, with an unpaired two-tailed t-test P value of 0.24 (Fig 3.50.). 
Hence, this finding, was not deemed statistically significant, as both P values were 
higher than the significance interval of 0.05. 
Following this encouraging result pUKC3400 and pUKC3401 plasmids were 
transformed into BY4741 and DN5 and 2736 was freshly transformed to perform 




Fig 3.50. Percentage of fluorescent cells in populations of 2736 expressing 
native GPx7 and GPx8 in presence and absence of 2mM H2O2. 
A population of 10,000 cells measured by flow cytometry with a baseline for each 
strain set at 50% fluorescent cells before the addition of H2DCFDA ROS probe dye. 
The increase in percentage of fluorescent cells as a result of addition of just 
H2DCFDA (black) and H2DCFDA with 2mM H2O2 (grey) are shown for 2736 
expressing native GPx7 and GPx8 with a pBEVY-/FRQWURODQG¨FR[VWUDLQSRVLWLYH
control. Experiment performed in biological triplicate with standard error bars are 

















































































































H2DCFDA H2DCFDA + 2mM H2O2
Fig 3.52. Percentage of fluorescent cells in populations of 2736 expressing native 
GPx7 and GPx8 in presence and absence of 2mM H2O2. 
A population of 10,000 cells measured by flow cytometry with a baseline for each strain 
set at 50% fluorescent cells before the addition of H2DCFDA ROS probe dye. The 
increase in percentage of fluorescent cells as a result of addition of just H2DCFDA 
(black) and H2DCFDA with 2mM H2O2 (grey) are shown for 2736 expressing native GPx7 
and GPx8 with a pBEVY-/FRQWURODQG¨FR[VWUDLQSRVLWLYHFRQWURO([SHULPHQW

























































H2DCFDA H2DCFDA + 2mM H2O2
Fig 3.51. Percentage of fluorescent cells in populations of BY4741 expressing 
native GPx7 and GPx8 in presence and absence of 2mM H2O2. 
A population of 10,000 cells measured by flow cytometry with a baseline for each strain 
set at 50% fluorescent cells before the addition of H2DCFDA ROS probe dye. The 
increase in percentage of fluorescent cells as a result of addition of just H2DCFDA 
(black) and H2DCFDA with 2mM H2O2 (grey) are shown for BY4741 expressing native 
GPx7 and GPx8 with a pBEVY-/FRQWURODQG¨FR[VWUDLQSRVLWLYHFRQWURO([SHULPHQW








The data from these experiments did not match the correlation seen in the initial 
experiment, in all 3 of these experiments there was a large variability between 
experimental biological triplicates shown by the standard error bars (Fig 3.51. ± Fig 
3.53.). Due to the standard error of the data a reliable conclusion could not be drawn 
as for the averages of some strains there was a decrease in percentage of 
fluorescent cells after addition of the dye and strains that after addition of H2O2 had 
lower percentages of fluorescent cells than without H2O2 (Fig 3.51. ± Fig 3.53.). The 
potency of the dye was therefore questioned. 
A fresh H2DCFDA dye stock was made rather than using pre-existing stocks as 
freeze-thaw cycles may have resulted in degradation of the dye. This was used to 
perform FACS analysis on freshly transformed BY4741, 2736 and DN5 strains with 




Fig 3.53. Percentage of fluorescent cells in populations of DN5 expressing native 
GPx7 and GPx8 in presence and absence of 2mM H2O2. 
A population of 10,000 cells measured by flow cytometry with a baseline for each strain 
set at 50% fluorescent cells before the addition of H2DCFDA ROS probe dye. The 
increase in percentage of fluorescent cells as a result of addition of just H2DCFDA 
(black) and H2DCFDA with 2mM H2O2 (grey) are shown for DN5 expressing native GPx7 
and GPx8 with a pBEVY-/FRQWURODQG¨FR[VWUDLQSRVLWLYHFRQWURO([SHULPHQW

























































Fig 3.54. Percentage of fluorescent cells in populations of BY4741 expressing 
native GPx7 and GPx8 in presence and absence of 2mM H2O2. 
A population of 10,000 cells measured by flow cytometry with a baseline for each strain 
set at 50% fluorescent cells before the addition of H2DCFDA ROS probe dye. The 
increase in percentage of fluorescent cells as a result of addition of just H2DCFDA 
(black) and H2DCFDA with 2mM H2O2 (grey) are shown for BY4741 expressing native 
GPx7 and GPx8 with a pBEVY-/FRQWURODQG¨FR[VWUDLQSRVLWLYHFRQWURO([SHULPHQW



































































































H2DCFDA H2DCFDA + 2mM H2O2
Fig 3.55. Percentage of fluorescent cells in populations of 2736 expressing 
native GPx7 and GPx8 in presence and absence of 2mM H2O2. 
A population of 10,000 cells measured by flow cytometry with a baseline for each 
strain set at 50% fluorescent cells before the addition of H2DCFDA ROS probe dye. 
The increase in percentage of fluorescent cells as a result of addition of just H2DCFDA 
(black) and H2DCFDA with 2mM H2O2 (grey) are shown for 2736 expressing native 
GPx7 and GPx8 with a pBEVY-/FRQWURODQG¨FR[VWUDLQSRVLWLYHFRQWURO([SHULPHQW





BY4741 and 2736 strains showed the expected trend of having an increase in 
numbers of fluorescent cells as a result of addition of the H2DCFDA dye and then 
an even greater increase from addition of H2O2 (Fig 3.54., Fig 3.55.). 
Nevertheless, there was no statistically significant change in levels of intracellular 
H2O2 as a result of expression of GPx7 and GPx8, with no unpaired two-tailed t-
test P value less than the significance interval of 0.05. There was also a large 
degree of standard error in all of these samples with a large amount of variability 
between replicates (Fig 3.54., Fig 3.55.). 
The analysis of the DN5 FACS data showed peculiar results, with large amounts of 
error as well as for some strains having lower numbers of fluorescent cells after the 
addition of H2O2 (Fig 3.56.). This was the last experiment to be performed from the 
new dye stock and so the freeze thawing from the first 2 experiments may have 
resulted in dye expiration. 
7KH¨FR[VWUDLQDVWUDLQLQZKLFKWKH&\WRFKURPH&subunit 4 has been knocked 
out and hence has decreased detoxification of H2O2, was used as a positive control, 
Fig 3.56. Percentage of fluorescent cells in populations of DN5 expressing native 
GPx7 and GPx8 in presence and absence of 2mM H2O2. 
A population of 10,000 cells measured by flow cytometry with a baseline for each 
strain set at 50% fluorescent cells before the addition of H2DCFDA ROS probe dye. 
The increase in percentage of fluorescent cells as a result of addition of just H2DCFDA 
(black) and H2DCFDA with 2mM H2O2 (grey) are shown for DN5 expressing native 
GPx7 and GPx8 with a pBEVY-/FRQWURODQG¨FR[VWUDLQSRVLWLYHFRQWURO([SHULPHQW
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however, consistently throughout the flow cytometry experiments a dramatic 
increase in fluorescence as a response to addition of H2DCFDA in this strain was  
not witnessed (Fig 3.50. ± Fig 3.58.).  
 
3.2.4.2 Intracellular hydrogen peroxide in BY4741 expressing glutathione 
peroxidases 7 and 8 constructs 
Following a negligible decrease in intracellular H2O2 as a result of expressing native 
GPx7 and GPx8 BY4741 was transformed with plasmids pUKC3404, pUKC3405, 
pUKC3406 and pUKC3407 and hence expressed GPx7 and GPx8 with ER retention 
sequences only and ER retention sequences as well as ER signal sequences. 
Therefore if residing in the ER was essential to GPx7 and GPx8 mediated H2O2 
detoxification this would be indicated through FACS analysis. 
Expressing GPx7 and GPx8 in BY4741 resulted in a decrease in the mean 
percentage of fluorescent cells compared with the pBEVY-L control in both the 
absence and presence of H2O2 (Fig 3.57.). Expression of either GPx7 ER 
localisation signal construct caused a greater decrease than that of GPx8 in the 
presence of just H2DCFDA dye, while in the presence of H2DCFDA as well as 2mM 
Fig 3.57. Percentage of fluorescent BY4741 cells expressing GPx7 and GPx8 with 
ER retention sequence from addition of H2DCFDA and addition of 2mM H2O2. The 
LQWUDFHOOXODUOHYHOVRI526DUHLQGLFDWHGE\WKHSHUFHQWDJHRIIOXRUHVFHQWFHOOVWKH¨FR[
positive control strain was used as well as BY4741 transformed with pBEVY-L empty 
vector from which the changes in percentage of fluorescent cells for BY4741 expressing 
pUKC3404 and pUKC3405 was compared to. Experiment repeated in biological triplicate 
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H2O2 it appears that GPx7 and GPx8 with both ER retention sequence as well as 
ER signal sequence caused a greater decrease in percentage of fluorescent 
cells(Fig 3.57.). However, due to the wide variability between replicates none of the 
GPx7 or GPx8 constructs had an unpaired two-tailed t-test P value less than the 
significance interval of 0.05, and hence no statistically significant change in 
percentage of fluorescent cells, and by extension, intracellular H2O2. 
3.2.4.3 ,QWUDFHOOXODU K\GURJHQ SHUR[LGH LQ D ¨pdi1 strain expressing 
glutathione peroxidases 7 and 8 constructs  
)RUVLPLODUUHDVRQVWRD¨ pdi1 strain was tested to check if GPx7 and GPx8 
had any in vivo effect on detoxification of H2O2. Using FACS analysis for intracellular 
H2O2 gave a more direct measurement of this, whereas growth curve analysis are 
influenced by more factors. 
Intracellular ROS concentrations are relatively unaffected in DN5 as a result of 
expressing ER localised GPx7 and GPx8 proteins. The two strains expressing GPx8 
constructs had mean percentages of fluorescent cells roughly half that of the 
pBEVY-L control in absence of H2O2, while expression of the GPx8 constructs 
resulted in percentages of fluorescent cells approximately the same as the control 
in the absence of H2O2 (Fig 3.58.). Additionally, only in DN5 expressing GPx7 with 
ER retention sequence only was there a decrease in percentage of fluorescent cells 
that did not overlap standard error bars with the control (Fig 3.58.). Nevertheless, 
results for change in percentage of fluorescent cells in both presence and absence 
of H2O2 were not deemed statistically significant, as no unpaired two-tailed t-test P 
values were less than the significance interval of 0.05, and hence expression of 








3.2.5 Effects of glutathione peroxidases 7 and 8 on the rate of oxidative folding 
in vivo 
GPx7 and GPx8 couple H2O2 peroxide generated from disulphide bond formation to 
Pdi1p oxidation enabling it to further form disulphide bonds hence increasing the 
rate of OPF. GPx7 and GPx8 may therefore have a similar effect when transformed 
into yeast. 
3.2.5.1 Sensitivity of BY4741 expressing glutathione peroxidases 7 and 8 
constructs to 1,4 -Dithiothreitol 
To investigate the ability of GPx7 and GPx8 to assist PDI increasing the rate of OPF 
1,4-Dithiothreitol (DTT) was using. DTT is a powerful reducing agent that prevents 
OPF(RH). Through disulphide exchange reactions it non discriminately reduces 
folded protein causing them to unfold while itself entering the oxidised state forming 
a 6 membered ring(89). This leads to triggering of the Unfolded Protein Response 
(UPR) as a result of the increased ER stress. DTT inhibits growth through its effects 
Fig 3.58. Percentage of fluorescent cells in populations of DN5 expressing GPx7 
and GPx8 constructs in presence and absence of 2mM H2O2. 
A population of 10,000 cells measured by flow cytometry with a baseline for each strain 
set at 50% fluorescent cells before the addition of H2DCFDA ROS probe dye. The 
increase in percentage of fluorescent cells as a result of addition of just H2DCFDA and 
H2DCFDA with 2mM H2O2 are shown for DN5 expressing GPx7 and GPx8 constructs 
with a pBEVY-/FRQWURODQG¨FR[VWUDLQSRVLWLYHFRQWURO([SHULPHQWZDVSHUIRUPHGLQ
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and therefore a strain more efficient at OPF can better counteract the reductive 
activity of DTT and hence growth inhibition is decreased. 
Growth of BY4741 strains expressing GPx7 and GPx8 constructs on YNB-Ura 
medium with 0mM to 5mM DTT shows no changes in resistance to DTT when 
compared with a BY4741 control transformed with pBEVY-L (Fig 3.59.). The 
increment from 2.5mM to 5mM is larger than any of the prior increments and as a 
result only moderate impairment to growth was seen in 2.5mM DTT while there was 
Fig 3.59. Growth of BY4741 expressing GPx7 and GPx8 constructs at 
varying cell densities on solid YNB-Ura medium in 0mM to 5mM DTT 
BY4741 strain yeast transformed with pBEVY-L control, pUKC3404, 
pUKC3405, pUKC3406 and pUKC3407 plated onto YNB-Leu Agar by 
replica plating in 4 1/10 serial dilutions from OD600 10-2 to OD600 10-5 with 




no growth at 5mM. Concentrations of DTT up to 10mM were used as growth on drop 
out medium containing 10mM DTT was seen in the work of L.Hjelmqvist(90), 
however, no growth seen at 10mM during this experiment and so data omitted. 
3.2.5.2 Secretion of an over expressed extracellular disulphide bonded protein 
To test for the efficiency of disulphide bond formation a PDI expressing strain and a 
¨pdi1 were transformed with plasmid pVT100U-K1 encoding for the secreted K1 
toxin: a heterodimeric protein containing three disulphide bonds(91) which induces 
cell death of sensitive strains through formation of a membrane pore(92).  
3.2.5.2.1 Levels of killer toxin secretion in BY4741 expressing native 
glutathione peroxidases 7 and 8 
BY4741 was simultaneously transformed with pVT100U-K1 and pUKC3400, 
pUKC3401 or pBEVY-L control. Whether native GPx7 or GPx8 had any effect on 
killer toxin secretion, and by extension OPF, was assayed for by calculating the area 
of a zone of killer toxin mediated clearing of sensitive S6 strain around cells 
expressing killer toxin, which were added to an antimicrobial disk on an agar 
containing the S6 strain. The area of the zone of killing is therefore directly 
proportional to the levels of K1 toxin secretion. 
Fig 3.60. Area of the zone of killing resulting from expression of the disulphide 
bonded secretory protein: killer toxin in BY4741 expressing native GPx7 and GPx8. 
The secretion of killer toxin by strains transformed with pVT100U-K1 plasmid results in 
formation of a zone of killing surrounding the antimicrobial disk on which they were 
added. The area of the zone of killing was measured using ImageJ 1.x(93). BY4741 
expressing native GPx7 and GPx8 was compared to BY4741 pBEVY-L control, ski4 
natural killer toxin secretor control also used. Experiment performed in biological and 





















The area of the zone of killing for both BY4741 expressing native GPx7 and GPx8 
does not statistically significantly differ from the area of the pBEVY-L control strain 
(Fig 3.60.), as the unpaired two-tailed t-test P values are 0.75 for GPx7 and 0.99 for 
GPx8. Neither of these P values are less than the significance interval of 0.05. 
Therefore GPx7 and GPx8 has no effect on levels of killer toxin secretion, and thus 
no effect on oxidative folding in vivo.  
3.2.5.2.2 Levels of killer toxin secretion in BY4741 expressing glutathione 
peroxidases 7 and 8 constructs 
-2For GPx7 or GPx8 to oxidise Pdi1p they must be localised to the ER, and therefore 
GPx7 and GPx8 constructs with ER localisation signal were used to check whether 
the lack of ability for native GPx7 and GPx8 to increase the rate of OPF was intrinsic 
to the interaction of GPx7 and GPx8 with yeast Pdi1p or whether it was a result of 
not being localised to the ER.  
 
The expression of GPx7 and GPx8 constructs in BY4741 did not result in a 
statistically significant increase in the area of the zone of killing, with no unpaired 
Fig 3.61. Area of the zone of killing resulting from expression of the disulphide 
bonded secretory protein: killer toxin in BY4741 expressing GPx7 and GPx8 
constructs. 
The secretion of killer toxin by strains transformed with pVT100U-K1 plasmid results in 
formation of a zone of killing surrounding the antimicrobial disk on which they were 
added. The area of the zone of killing was measured using ImageJ 1.x(93). BY4741 
expressing GPx7 and GPx8 constructs were compared to BY4741 pTH644 control, 
ski4 natural killer toxin secretor control also used. Experiment performed in biological 
































two-tailed t-test P value less than the significance interval of 0.05, with the exception 
of BY4741 transformed with pUKC3404. GPx7 with an ER retention sequence only 
gave a very slight, but statistically significant, increase in the area by ~0.2cm2,
 -
approximately a 7% increase (Fig 3.61.). This unpaired two-tailed t-test P value was 
0.041; less than the significance interval of 0.05. Overall, expression of GPx7 and 
GPx8 in BY4741 did not result in a dramatic increase in killer toxin secretion, and 
therefore OPF. 
3.2.5.2.3 /HYHOVRINLOOHU WR[LQVHFUHWLRQLQD¨pdi1 strain expressing native, 
and chimeric construct versions of glutathione peroxidases 7 and 8 
GPx7 and GPx8 require an interaction with Pdi1p to increase OPF, therefore 
H[SUHVVLRQRI*3[DQG*3[LQD¨pdi1 strain would not result in an increase in 
rate of OPF and thus it would not be expected that there would be an increase in 
killer toxin secretion. 
 
Secretion of the disulphide bonded killer toxin from DN5 strains is significantly lower 
than that of BY4741, there was also no statistically significant increase in killer toxin 
Fig 3.62. Area of the zone of killing resulting from expression of the disulphide 
bonded secretory protein: killer toxin in DN5 expressing native GPx7 and GPx8 as 
well as GPx7 and GPx8 constructs. 
The secretion of killer toxin by strains transformed with pVT100U-K1 plasmid results in 
formation of a zone of killing surrounding the antimicrobial disk on which they were 
added. The area of the zone of killing was measured using ImageJ 1.x(93). DN5 
expressing GPx7 and GPx8 constructs was compared to DN5 pTH644-L control, ski4 
natural killer toxin secretor control also used. Experiment performed in biological and 















































secretion resulting from expressing GPx7 or GPx8, with no P value of an unpaired 
two-tailed t test less than the significance interval of 0.05, with the exception of the 
increase in killer toxin resulting from expression of native GPx7 in which there was 
an increase from 0.77cm2 to 1.08cm2 (Fig 3.62.), having an unpaired two-tailed t-
test P value of 0.0049; less than the significance interval of 0.05. There was also a 
dramatic decrease to no detectable killer toxin secretion for DN5 transformed with 
GPx7 constructs that localise to the ER (Fig 3.62.).  
3.2.5.3 Effect of glutathione peroxidases 7 and 8 on rate of expression of an 
intracellular disulphide bonded protein 
To assay for the levels of expression of an intracellular disulphide bonded protein in 
BY4741 and DN5 expressing native GPx7 and GPx8 as well as GPx7 and GPx8 
constructs gaussia luciferase was used, encoded for by the GLuc plasmid. This 
plasmid was transformed into strains of interest along with a PGK loading control 
and a western blot performed to ascertain levels of expression. Although bands 
corresponding to PGK were seen, bands at ~19kDa, that would indicate expression 
of gaussia luciferase, were not seen. An intracellular gaussia luciferase positive 
control was not available and so it cannot be assumed that absence of bands means 
the strains were not expressing gaussia luciferase over a potential problem with 
imaging of the western blot. 
3.2.6 The effect of glutathione peroxidases 7 and 8 on oxidative folding with 
yeast Pdi1p in vitro 
As assays performed for the efficiency of OPF in vivo suggested that GPx7 and 
GPx8 were unable to interact with yeast Pdi1p, this was also explored in vitro. The 
effect that GPx7 and GPx8 had on the OPF ability of yeast Pdi1p in vitro was tested 
to see whether there was a direct lack of interaction between GPx7 and GPx8, or 
whether the inhibition of interaction came about through some other means in vivo. 
Consumption of ambient oxygen in a closed system can be used as an indicator for 
the rate of OPF, as for each disulphide bond formed an oxygen molecule is 
converted to H2O2. The oxygen consumption with time for 5µM Pdi1p with 1µM 
Ero1p and 40mM free thiol GSH substrate without, or with, GPx7 or GPx8 was 












Sample Mean Max Rate (d(O2 levels)/d(time)) 
No GPx7/8 2.05x10-3 +/-1.5x10-4 
GPx7 2.5x10-3 +/-3x10-4 
GPx8 2.15x10-3 +/-5x10-5 
Fig 3.63. Levels of oxygen consumption with time to indicate rate of in vitro 
disulphide bond formation by Pd1p and the changes in this rate resulting from 
presence of native GPx7 and GPx8. 
The consumption of ambient oxygen in a closed system from the activity of 5µM 
yPdi1p and 1µM Ero1p with 40µM free thiol GSH substrate indicated rates of 
disulphide bond formation in vitro, GPx7 and GPx8 were added to investigate as to 
whether these proteins were able to supplement oxidative folding. Experiment was 
performed in duplicate and standard error bars shown 
Fig 3.64. Mean max rate of oxygen consumption for PDI, Ero1p and GSH, in the 
absence and presence of GPx7 and GPx8. 
The mean max rate calculated from the oxygen consumption assay (Fig 3.62.) in 
presence and absence of GPx7 and GPx8. The range of data is shown next to the 



























GPx8 had a very similar curve to that of the control, while the curve for GPx7 
suggested an increased rate of oxygen consumption (Fig 3.63.). The mean max 
rate of oxygen consumption for each sample, however, indicated that there was no 
statistically significant difference between the rates as although GPx7 had a mean 
max rate 4.5x10-4 s-1 greater than that of the control (Fig 3.64.), this finding is not 
statistically significant as it has an unpaired two-tailed t-test P value of 0.318; 
greater than the significance interval of 0.05. Therefore, native GPx7 and GPx8 
have no impact upon rate of oxygen consumption, and by extension, disulphide 
bond formation in vitro.   
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Chapter 4 ± Discussion 
Many pharmaceutical products are produced in biological systems, and hence are 
termed biopharmaceuticals. Many of these biopharmaceuticals require oxidative 
folding and hence this is a limiting factor in their production. There is much yet to be 
discovered regarding the yeast oxidative protein folding pathway, in particular the 
role that the PDI homologues play. Better characterisation of this pathway will allow 
for adaption of the yeast ER to increase in vivo oxidative folding. 
As these disulphide bonded biopharmaceuticals need to be produced in large 
amounts they are overexpressed. In a eukaryotic system this leads to rapid 
production of H2O2 as a result of the oxidative folding pathway. As this generation 
of ROS is beyond what was evolutionarily required of the organism it is surely a 
limiting factor in biopharmaceutical production. Therefore through expression of 
recombinant proteins that alleviate this ROS stress the limiting factor can be 
removed and the rate of oxidative folding increased.  
&DQYLDEOH¨pdi1 mutants be generated? 
In yeast pdi1 is an essential gene, however, it is not clear as to exactly why this as 
overexpression of PDI homologues Mpd1p and Mpd2p are both able to rescue 
viability of a ¨pdi1 strain. Therefore to investigate whether there is a mutation that 
would rescue viability following a pdi1 knock out viable ¨pdi1 mutants were 
screened for.  
2YHUWKHFRXUVHRIWKHSURMHFWILYHVSRQWDQHRXVO\DULVLQJYLDEOH¨ pdi1 mutants were 
isolated together with a further 15 following UV mutagenesis. All of these mutants 
were selected due to their resistance to 5-)2$ XVLQJ D VWUDLQ FDUU\LQJ D ¨pdi1 
knockout covered by a plasmid-borne copy of the PDI1 gene with a URA3 selectable 
marker. Resistance to 5FOA would suggest these mutants had lost the URA3-PDI1 
plasmid, but Western blot analysis showed that all but 2 of the mutants (PDISR4 
and PDISR5) were still expressing PDI (Fig 3.5., Fig 3.6.). Neither of these two 
YLDEOH¨pdi strains could be revived from -Û&JO\FHUROVWRFNVOLNHO\GXHto cell wall 
instability. This may have occurred as disulphide bonds are required for the stability 
of the yeast cell wall. 1,3-beta-glucanosyltransferases are responsible for 
biogenesis of the yeast cell wall and require oxidative folding for their activity(95)(96).   
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$VWKHVHPDMRULW\RIWKH¨ pdi1 strains that were 5-FOA resistant were still expressing 
PDI, this indicated that the mutations leading to growth on 5-FOA media were 
unlikely to be ones that restored viability in the absence of PDI. For these mutants 
to emerge the simultaneous absence of plasmid and a suppressor to ¨pdi lethality 
(supX) would be required. Instead a recombination event may be occurring, in which 
the PDI1 gene from the plasmid inserts into the genome and the URA3 gene is lost, 
hence resulting in 5-FOA resistance while maintaining expression of PDI. Another 
possible explanation is a mutation resulting in direct increased resistance to 5-FOA, 
either through inhibited 5-FOA uptake, or its conversion to 5-FU (Fig 3.1) 
Inhibited uptake of 5-FOA may be mediated by mutations that result in decreased 
activity in components of uracil salvage pathway, such as uracil permease which 
regulates the uptake of uracil(97). Alternatively, there is an S. cerevisiae protein with 
functional homology to that of the human organic anion transporter (OAT2), which 
in humans has been shown to transport orotic acid, the unmodified analogue to of 
5-FOA(98).  
The inhibited conversion of 5-FOA to 5-FU may also have occurred through a 
mutation resulting in downregulation of expression of the URA3 or URA5 genes 
such as in cis- and trans-Acting regulatory elements(99) or through a mutation that 
decreases the activity of the products of URA3 and URA5: OCDase and 
OPRTase(100) respectively, through a point mutation that results in a missense or 
nonsense mutation. 
All of the 5FOA resistant strains, ZLWK WKH H[FHSWLRQ RI RQH RI WKH ¨pdi1 mutant 
PDISR1-5, showed growth on YNB-Ura medium, albeit papillae growth (Fig 3.3., Fig 
3.4.). This suggests that either the URA3 gene is being retained and resistance to 
5-FOA is mediated through mutation affecting uptake or its conversion to 5-FU. A 
URA3 point mutation that may have resulted in decreased expression, or activity, of 
the ODCase protein, hence providing 5FOA resistance may be reverting in some of 
cells of the population plated onto YNB-Ura selective media, explaining the papillae 
growth. 
 Another explanation is that due to a reversion event of the missense point mutation 
in the genomic ura3-1 allele the wild type URA3 gene is restored. In the PDIS/MRx 
mutants, however, this reversion event appeared to occur at a much higher 
frequency than the homozygous ura3/ura3 diploid heterozygous ura3-1/ura3-52 
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DN5 control strain (Fig 3.4.). This result is unsurprising as the most likely 5-FOA 
resistant strains, either through loss of the plasmid and a supX mutation, or through 
a mutation that directly inhibits the cytotoxic mechanism of 5-FOA, would most likely 
occur in a strain with impaired proofreading ability, such as through point mutations 
ZLWKLQWKHFRQVHUYHG)',(7UHJLRQWKDWUHVXOWVLQORZHUHG¶-¶H[RQXFOHDVHDFWLYLW\
of DNA polymerases(101)(102). As a result of the lowered mismatch repair 
mechanisms the reversion of ura3-1 in the PDIS/MRx mutants would occur at a 
higher frequency. 
The growth of the PDIS/MR1x strains in YEPD showed consistently that all of the 
mutants had a lag phase of increased duration when compared to the 2736 control 
strain (Fig 3.8., Fig 3.9.). This supports the hypothesis of direct resistance to the 
cytotoxic effects of 5-FOA as the transition of a stationary phase culture to entry of 
log phase quickly requires rapid protein synthesis to adapt to the new conditions. A 
strain with decreased uracil uptake or impaired OCDase or OPRTase activity would 
produce uridine monophosphate at a slower rate, slowing formation of nascent 
mRNA and with it a reduction in protein synthesis.  
As the likelihood of the emergence of a strain that had lost the PDI1-URA3 plasmid 
and had a supX mutation appeared to be low compared to generating strains that 
retained the pdi1 gene but gained 5-FOA resistance, alternate approaches should 
be considered. One possible approach is to use 2736 strain yeast with increasing 
concentrations of DTT to select for a mutant that is more resistant to increased 
unfolded protein, as would be expected to occur in a pdi1-defective strain. The 
reducing agent DTT causes an increase in unfolded protein and ER oxidative stress 
by indiscriminately reducing disulphide bonded proteins(90). The mutants with 
increased resistance to unfolded protein would then be transferred to plates 
containing 5-FOA to select for loss of the PDI1-URA3 plasmid and hopefully to 
VXFFHVVIXOO\JHQHUDWH¨pdi1 strains with viability restored by a secondary mutation 
i.e. supX. This was attempted in a preliminary experiment where 5 colonies of 2736 
strain were grown on 20mM DTT, then transferred to 30mM DTT. However, at higher 
concentrations of DTT cells grew considerably slower and so emergence of colonies 
on higher concentrations of DTT could not be attributed to increased DTT resistance 
rather than degradation of DTT, as it is a temperature sensitive compound. 
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$QDOWHUQDWHVWUDWHJ\WRJHQHUDWHYLDEOH¨pdi1 supX mutants without inducing direct 
resistance to 5-FOA would be to place the expression of the PDI1 gene under the 
control of a tetracycline-regulated promoter system(103). Through gradual decrease 
in the concentration of tetracycline or doxycycline(104) in the solid medium one could 
select for cells that emerge on lower concentrations of tetracycline or doxycycline. 
7KLVZLOOJUDGXDOO\VHOHFWIRU¨ pdi1 supX mutants that retain viability on solid medium 
with no tetracycline or doxycycline and hence no expression of PDI1; such mutants 
should have supX. Rather than a plasmid based expression system ideally the PDI1 
gene should be integrated into the genome under the control of the tetracycline 
expression system. This would prevent a recombination event resulting in removal 
of the tetracycline promoter. 
It is therefore apparent that pdi1 is an essential gene as although PDISR4 and 
PDISR5 are ¨pdi1 strains, it is clear that there is a low frequency mutation that 
results in this maintained viability. Therefore there is not a native mechanism for the 
upregulation of any of the PDI homologues, or at least not to a level at which viability 
is maintained. 
4.2 What are the impacts of expression of native human glutathione 
peroxidases 7 and 8 in yeast?  
4.2.1. Engineering expression of glutathione peroxidases 7 and 8 in yeast 
It was hypothesised that the expression of GPx7 and GPx8 in yeast would have 
increased the rate of oxidative folding as they utilise intracellular H2O2 produced by 
Ero1p to oxidise PDI. Therefore there would also be a decrease in levels of 
intracellular H2O2.This would alleviate ROS stress under constitutive expression of 
a disulphide bond containing protein and increase the rate of oxidative folding of this 
protein.  
To investigate whether native GPx7 or GPx8 was able to detoxify H2O2 in vivo 
cDNAs encoding one or the other were expressed in yeast. Sensitivity to H2O2 was 
then investigated through growth curves (Fig 3.25 ± Fig 3.33) and a sensitivity assay 
for growth on solid media in concentrations of 0mM to 4mM H2O2 (Fig 3.48), both of 
these showed no increase in resistance to H2O2 as a result of expressing native 
human GPx7 or GPx8. A more direct measure on levels of intracellular H2O2 was 
also performed using an intracellular ROS detector dye: H2DCFDA in conjunction 
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with FACS analysis. Although an initial experiment showed statistically significant 
changes in levels of intracellular ROS as a result of expressing GPx7 (Fig 3.50) this 
was not seen in any repeats of this experiment (Fig 3.54, Fig 3.55). These results 
therefore failed to support the hypothesis that expression of native GPx7 or GPx8 
would have a significant impact on H2O2 detoxification. 
To investigate the effects of native GPx7 and GPx8 on the rate of intracellular 
oxidative folding the levels of secretion of the disulphide bonded protein killer toxin 
was also measured (Fig 3.60.). This showed that neither GPx7 nor GPx8 had any 
statistically significant effect on the rate of oxidative folding in vivo. It was therefore 
considered that absence of yeast ER signal sequences or retention sequences was 
resulting in either cytoplasmic localisation of these ER proteins or that there was 
secretion of the protein and this was further investigated. 
4.2.2 Identifying Native GPx7 and GPx8 localisation 
To conclude as to whether native GPx7 and GPx8 were localised to the ER or 
cytoplasm, an attempt was made to create GFP fusions of these proteins using 
plasmid p6431 (Fig 2.1.). PCR was used to amplify GPx7 and GPx8 for insertion 
into the p6431 vector, but following ligation and purification the DNA, the yield was 
very low and similarly a low number of E.coli transformants were present. A 
sequence of the plasmid was provided by Tuite, M.F. (School of Biosciences, 
University of Kent) and a second XbaI restriction site was located 219 bp upstream 
of the gene insert site in the CUP1 promoter in plasmid p6431. The presence of this 
second XbaI site would have led to ligation failure as not only could the complete 
vector with insert have formed, but additional DNA fragments of would be generated. 
A double restriction digest of the plasmid with BamHI and XbaI did not show the 
~220bp fragment by agarose gel (Fig 3.16), however, it is likely due to its small size 
to have migrated off the gel.  
Additional DNA fragments were seen on the agarose gel used for gel extraction and 
purification following the restriction digest in preparation of native human GPx7 and 
GPx8 for ligation into p6431. These were approximately 4kb for GPx7 and 3kb for 
GPx8. The sizes of pKEHS780 plasmid and Human GPx8 cDNA clone plasmid were 
4.2kb and 3.4kb respectively (table 2.1.6). The additional bands for contaminant 
DNA for GPx7 and GPx8 were approximately the size of their respective E.coli 
vectors and so may have been this vector in its linearised form. An additional DNA 
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band was also seen in the GPx8 control, albeit faint, that migrated to a similar 
position to that of the linearised human GPx8 cDNA vector. It is therefore likely that 
the linearised plasmid containing the cDNA of interest for PCR amplification was 
seen as a contaminant in the sample despite PCR purification. None of these DNA 
fragments were seen prior to double restriction digest and therefore the diffuse band 
that results from the multiple conformations of circularised DNA may have caused 
the residual plasmid not being detected.  
To identify intracellular localisation of GPx7 and GPx8 either an alternate plasmid 
for generating GFP fusions could be used or creation of new primers for the inclusion 
of any compatible pair of restriction enzymes between the CUP1 promoter and 
sGFP ORF in the p6431 vector (Fig 2.1.). This would avoid multiple cut sites as 
occurring from use of XbaI. 
4.3 Does addition of a yeast ER signal sequence and ER retention sequence 
to glutathione peroxidases 7 and 8 result in any favourable phenotypic 
characteristics? 
The retention of the expressed GPx7 and GPx8 in the cell was indicated by absence 
of these proteins in the medium as shown by western blot (Fig 3.23.) and so 
intracellular effects of these proteins would be expected if they were active in yeast. 
Due to the lack of success in generating GFP fusions the ER localisation of these 
protein constructs could not be directly confirmed.  
As a result of expressing GPx7 and GPx8 with yeast ER localisation signals the 
mean intracellular levels of H2O2 were observed to decrease compared to the 
control (Fig 3.57). However, the results were not statistically significant suggesting 
that neither GPx7 nor GPx8 were detoxifying H2O2 to a significant extent in vivo. 
Both GPx7 and GPx8 have been shown in vitro to be able to couple the 
detoxification of H2O2 with the oxidation of GSH(47), albeit at a much lower efficiency 
than that of PDI. However, this indicates that the utilisation of GSH by GPx7 and 
GPx8 to detoxify H2O2 either does not occur in vivo or at a rate undetectable by this 
assay.  
The growth of strains expressing ER localised GPx7 and GPx8 in presence of H2O2 
showed only a slight decrease in duration of lag phase at higher concentrations 
(2mM-4mM) of H2O2 compared with the control strain (Fig 3.40). The control strain 
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used, however, was BY4741 transformed with pBEVY-L plasmid, rather than a more 
appropriate control of BY4741 transformed with pTH644-L vector, as this is the 
plasmid backbone for plasmids pUKC3404-7. This transformation was attempted, 
but was unsuccessful and due to time constrains the pBEVY-L control was used. 
The pTH644-L vector is a derivative of pBEVY-L, however, there are important 
differences, namely that pTH644-L is a CEN/ARS low copy plasmid containing the 
CEN6 centromere and thus generating only 2-5 copies per cell while pBEVY-L is a 
2µ high copy plasmid containing 14-34 copies per cell(105), although copy number is 
dependent upon other gene(s) added to the plasmid. The growth rates of strains 
containing 2µ plasmids are typically lower than CEN/ARS strains(105), and hence 
may have resulted in pUKC3404 - 7 transformed strains having slightly higher 
growth rates than the pBEVY-L control. Coupled with the results from the flow 
cytometry analysis of the intracellular H2O2 it was therefore concluded that 
expression of GPx7 or GPx8 with ER localisation signal does not incur resistance 
to H2O2 DQG GRHVQ¶W OHDG WR IDVWHU JURZWK UDWHV LQ WKH DEVHQFH RI +2O2 when 
compared to a suitable control strain i.e. BY4741 + pTH644-L. Further support was 
provided by the observation that expression of GPx7 or GPx8 in yeast caused no 
change in levels of growth when cells were plated onto minimal medium containing 
0-4mM H2O2 (Fig 3.49).  
Despite the absence of an increase in H2O2 resistance, the expression of GPx7 and 
GPx8 could be contributing to a faster rate of oxidative folding in the yeast ER. This 
was measured through several ways, the first was to test for sensitivity to DTT, as 
proteins with more efficient oxidative folding efficiency would be more able to 
overcome the stresses incurred from an accumulation of unfolded protein within the 
ER caused by DTT. There was no increased resistance observed as a result of 
expressing GPx7 or GPx8, however, the concentrations of DTT were too widely 
spread to ascertain if there are subtle changes in resistance to DTT (Fig 3.59). 
Therefore in future experiments additional intermediate concentrations should be 
used as well as performing growth analyses in the presence of DTT to better 
characterise the effects GPx7 and GPx8 on oxidative stress in the yeast ER.  
Another method by which levels of oxidative folding were measured was by 
determining the levels of secretion of a disulphide bonded protein; killer toxin (Fig 
3.60, Fig 3.61). The only statistically significant increase in killer toxin secretion 
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observed was in cells carrying plasmid pUKC3404 encoding GPx7 with HDEL ER 
retention sequence. The strain transformed with pUKC3406, a GPx7 construct with 
both ER retention sequence and signal sequence, however, did not show this same 
trend. The area of the zone of killing for BY4741 expressing GPx7 with ER retention 
sequence and K1 toxin was only ~7% greater than the control, and GPx7 with both 
a yeast ER retention sequence and ER signal sequence gave no statistically 
significant effect on the rate of oxidative folding as judged by this assay. Therefore 
as GPx7 did not have a dramatic effect on the rate of oxidative folding it would be 
expected that it is not interacting, or is interacting with poor specificity, with the 
endogenous yeast PDI. Likewise the various GPx8 constructs, having no statistically 
significant change in oxidative folding as a result of their expression, would also not 
be expected to interacting with PDI. 
The secretion of another disulphide-bonded protein, Gaussia luciferase, was also 
attempted and levels of secretion were to be determined by Western Blot analysis. 
However, no bands were seen for Gaussia luciferase at 19kDa. As a PGK primary 
antibody was used along with the Gaussia Luciferase antibody as a control so that 
imageJ software could have been used to determine relative intensity of bands of 
Gaussia Luciferase to PGK. The presence of PGK may have interfered with the 
association of the GLuc Ig to the membrane as both PGK and GLuc antibodies were 
raised in rabbit hosts, this may result in cross-reactivity between the two primary 
antibodies. A repeat of this should be performed in absence of PGK to test 
exclusively for Gaussia Luciferase. Should the PGK1 primary antibody be the cause, 
an alternative loading control such as an antibody to actin could be used. 
Furthermore, a luciferase assay could be performed to produce quantitative results 
for intracellular levels of active, secreted Gaussia luciferase. 
An in vitro study of the interactions between yPDI with GPx7 and GPx8 showed that 
these proteins have no effect on the rate of oxygen consumption in a system of yPDI 
and yEro1p with GSH substrate. The recycling of H2O2 by GPx7 or GPx8 formed 
from the reduction of molecular oxygen as the final electron acceptor resulting in re-
oxidation of PDI would be expected caused a faster rate of oxygen consumption. 
This is due to more PDI kept in the oxidised form and hence a greater number of 
oxidative folding reactions can occur per second in the system. This indicates that 
in vitro GPx7 and GPx8 are unable to utilise H2O2 to re-oxidise yPDI (Fig 3.63, Fig 
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3.64). Further investigations are required to characterise the mechanism of this 
inhibited interaction. GPx7 and GPx8 may still be able to detoxify H2O2 in the system 
by utilising GSH as an electron donor(47), or by forming an intramolecular disulphide 
bond to remove the sulfenic acid group formed as the first step of H2O2 
detoxification.  
This in vitro assay could be improved through use of an alternate substrate that 
requires oxidative folding by PDI such as reduced ribonuclease A(102), as GSH has 
been shown to be a substrate for both GPx7 and GPx8(47)(50). This would ensure that 
GPx7 and GPx8 have no alternate substrate to yPDI, as due to the stoichiometric 
excess of GSH substrate there may be competition between GSH and yPDI as a 
substrate for GPx7 and GPx8(52).  
Overall there appears to be no interaction of GPx7 and GPx8 with yPDI both in vitro 
and in vivo, therefore to increase the rate of oxidative folding in yeast cells human 
PDI, human Ero1p, instead of their endogenous homologues and GPx7 or GPx8 
should be expressed in yeast simultaneously. Both GPx7 and GPx8 have been 
shown to interact with hPDI(47) while hEro1p would be required for proper reoxidation 
of hPDI. 
4.4 Does expression of glutathione peroxidases 7 and 8 result in any changes 
to the pKHQRW\SHRID¨pdi1 strain? 
As GPx7 and GPx8 have been shown to be able to oxidise hPDI, these proteins 
ZHUHDOVRH[SUHVVHGLQ'1DYLDEOH¨pdi strain. This was to compare whether the 
phenotypic changes that occur as a result of GPx7 and GPx8 expression differ from 
that of transformed BY4741. For all experiments with DN5 transformed with GPx7 
and GPx8, with the exception of an assay for the secretion of a disulphide bonded 
protein, pBEVY-L empty vector control was used, as again transformation with the 
more suitable control plasmid of pTH644-L empty vector was unsuccessful.  
The control strain showed growth characteristics distinct from those shown by the 
GPx7 and GPx8 expressing strains as the growth of the control had extensive 
spiking as well as reaching stationary phase at OD600 ~1.9, while the strains 
expressing GPx7 and GPx8 reached stationary phase at OD600 ~2.1 (Fig 3.41-3.45). 
Spiking of the control strain was only seen at 0mM and 2mM H2O2 concentrations 
(Fig 3.41, Fig 3.43), therefore spiking is likely to have resulted from contamination. 
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As many bacterial species commonly aggregate in liquid media(106) this would result 
in spiking of the growth curve cell aggregates come between the lamp and detector, 
an absorbance reading that is artificially high for the sample will be produced.  
For all DN5 strains transformed with GPx7 and GPx8 constructs stationary phase 
was reached with a higher OD600 and therefore with a higher biomass than the DN5 
pBEVY-L control (Fig 3.41-3.45). This suggests less inhibition of growth at low 
nutrient availability. This may have been the result of differences between the 
pBEVY-L vector used as the control and the pTH644 plasmid as they are multicopy 
2µ and single copy CEN plasmids respectively. In any case this difference in 
biomass at which stationary phase is reached is not an indication of H2O2 resistance 
resulting from expression of GPx7 and GPx8.  
It was originally proposed that in the absence of PDI, GPx7 and GPx8 would be 
unable to link H2O2 detoxification with PDI oxidation. Hence they would either have 
to utilise an alternate substrate such as GSH which would not actively cycle between 
the reduced and oxidised form, or would auto-oxidise to remove the sulfenic acid 
group formed as a result of H2O2 detoxification. This would therefore result in a non-
perpetual system of H2O2 detoxification and hence there would be less of an effect 
on intracellular levels of ROS. Antagonistically, however, the absence of PDI, and 
hence its oxidative effects, would cause a more reducing ER in which the reduced 
states of GPx7 and GPx8 would be favoured and hence enabling them to detoxify 
H2O2.  
The intracellular levels of H2O2 in DN5 were unaffected by the presence of GPx7 or 
GPx8 (Fig 3.58). Although DN5 expressing GPx8 with ER retention sequence only 
and expressing GPx8 with both ER signal sequence and ER retention sequence 
appeared to have reproducibly lower levels of intracellular ROS in the absence of 
H2O2 stress, neither of these results were statistically significant.  
The absence of a statistically significant change in intracellular H2O2 levels support 
the original hypothesis that there would be no effect on intracellular H2O2 levels as 
a result of expressing GPx7 and GPx8 in a ¨pdi1 strain as GPx7 and GPx8 would 
be lacking PDI as a substrate. However, it was discovered that GPx7 and GPx8 had 
no effect on intracellular H2O2 in a strain expressing yPDI. Therefore there is no a 
definitive correlation that an absence of expression of yPDI leads to the inability of 
GPx7 and GPx8 to detoxify H2O2 utilising yPDI in vivo. The finding that there is no 
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statistically significant change in levels of intracellular H2O2 in both a strain 
expressing PDI and a ¨pdi1 strain provides further evidence of the inability of GPx7 
and GPx8 to utilise GSH to detoxify H2O2.  
Throughout the project FACS analysis had low repeatability as well as a relatively 
low increase in the percentage of fluorescent cells as a result of addition of the 
H2DCFDA dye. This wDVDOVREHHQHYLGHQWLQWKH¨ cox4 stain, reportedly a producer 
of high levels of intracellular H2O2(107) and which was used as a control strain. This 
was likely the result of the duration of incubation of cultures with H2DCFDA being 
too short for intracellular uptake of the dye to generate a sizable difference in the 
percentage of fluorescent cells as a result of the dye. The duration of this incubation 
phase could not be increased as the uptake of the dye was significantly impaired in 
minimal medium. As the gpx7 and gpx8 genes are carried on plasmids, YNB-Leu 
media was required to prevent loss of the plasmid and therefore the incubation step 
in YNB-Leu media and dye had to be limited to 2hrs. Genomic integration of the 
gpx7 and gpx8 would allow overnight growth in YPD with H2DCFDA.  
It was expected that levels of secretion of a recombinant disulphide-bonded protein 
would be reduced in the DN5 strain when compared to BY4741 strain as a result of 
impaired oxidative folding resulting from the absence of pdi1. Despite the absence 
of PDI there would have to be oxidative folding in order for the strain to remain 
viable. Furthermore, expression of GPx7 and GPx8 in DN5 would not result in an 
increase in oxidative folding as there is no PDI to keep in the oxidised form.   
There were no statistically significant changes in the levels of killer toxin (Fig 3.62), 
an homologous secreted disulphide-bonded protein, with the exception of DN5 
expressing ER localised GPx7 constructs. Expression of these constructs resulted 
in complete inhibition of killer toxin secretion. This was a trend that was not exhibited 
by strains expressing non-ER localised GPx7 or by expression of the GPx7 
constructs with ER localisation signals in BY4741 parent strain. The fact that only 
expression of GPx7 with ER localisation signals resulted in the prevention of killer 
toxin secretion may mean that disulphide bond formation was inhibited. However, if 
this was the case, a corresponding decrease in growth rate as a result would have 
been expected. Or perhaps only in the case of over expression of a disulphide-
bonded protein, as is the case for killer toxin, does GPx7 result in hindrance of 
disulphide bond formation rather than assistance. The reason why expression of 
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GPx7 resulted in this dramatic decrease in killer toxin secretion while GPx8 does 
not is not yet clear. As the viability following the pdi1 knock out in DN5 is most likely 
restored by a 116 amino acid long truncated form of PDI1(108) it is possible that the 
mechanism by which GPx7 and GPx8 bind substrate are different. This would result 
in GPx7 interacting with the truncated PDI and sequestering it, preventing its activity 
in disulphide bond formation, while GPx8 is unable to bind the same peptide 
fragment. Nevertheless, additional experiments are required to accurately 
characterise the mechanism, such as confirming the truncated PDI that restores 
viability to DN5 and performing in vitro analysis for test for interactions with both 
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